<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title>Frontiers in Pediatrics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pediatr.</abbrev-journal-title>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fped.2023.1133102</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Telomere dysfunction in some pediatric congenital and growth-related diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Bo</given-names></name><uri xlink:href="https://loop.frontiersin.org/people/2148745/overview"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Fu</surname><given-names>Jianhua</given-names></name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1418715/overview" /></contrib>
</contrib-group>
<aff><addr-line>Department of Pediatrics</addr-line>, <institution>Sheng Jing Hospital of China Medical University</institution>, <addr-line>Shenyang</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Tim S. Nawrot, University of Hasselt, Belgium</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Hala El-Bassyouni, National Research Centre, EgyptDeepavali Chakravarti, University of Texas MD Anderson Cancer Center, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Jianhua Fu <email>fujh_sj@126.com</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Specialty Section:</bold> This article was submitted to Children and Health, a section of the journal Frontiers in Pediatrics</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>03</day><month>04</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2023</year></pub-date>
<volume>11</volume><elocation-id>1133102</elocation-id>
<history>
<date date-type="received"><day>28</day><month>12</month><year>2022</year></date>
<date date-type="accepted"><day>20</day><month>03</month><year>2023</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Zheng and Fu.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Zheng and Fu</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Telomere wear and dysfunction may lead to aging-related diseases. Moreover, increasing evidence show that the occurrence, development, and prognosis of some pediatric diseases are also related to telomere dysfunction. In this review, we systematically analyzed the relationship between telomere biology and some pediatric congenital and growth-related diseases and proposed new theoretical basis and therapeutic targets for the treatment of these diseases.</p>
</abstract>
<kwd-group>
<kwd>telomere</kwd>
<kwd>telomerase (TERT)</kwd>
<kwd>pediatric diseases</kwd>
<kwd>infants</kwd>
<kwd>aging</kwd>
</kwd-group><contract-num rid="cn001">82071688</contract-num><contract-num rid="cn002">2020JH1/10300001</contract-num><contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor><contract-sponsor id="cn002">Joint plan of Liaoning Provincial key R&#x0026;D Guidance Plan Projects of Liaoning Province</contract-sponsor><counts>
<fig-count count="4"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="121"/><page-count count="0"/><word-count count="0"/></counts>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1.</label><title>Introduction</title>
<p>Telomeres are part of the genome at the end of a linear chromosome. The telomeric DNA of vertebrates is composed of TTAGGG repeats, which bind to a group of proteins that regulate their biological functions and protect them from being recognized as DNA damage. In DNA replication, the wear of the telomere length (TL) accompanies each division; hence, the telomere length gradually shortens with age. Further evidence shows that the TL wear caused by childhood stress and other factors is a risk factor for diseases in adulthood and even in later life (<xref ref-type="bibr" rid="B1">1</xref>). Lin et al. (<xref ref-type="bibr" rid="B2">2</xref>) proved that the early telomere wear in infants has a certain impact on their long-term growth. Consistent with this, TL abrasion is closely related to the development of the nervous system within 2 years after birth (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Increasing evidence show that telomere attrition is related to children&#x0027;s growth and pediatric diseases. Thus, we focus on the latest progress in understanding the molecular properties of telomere biology in some pediatric diseases.</p>
</sec>
<sec id="s2"><label>2.</label><title>Telomere dysfunction in preterm infants</title>
<p>Approximately, 15 million children are born preterm (at 37 weeks gestational age) yearly worldwide. Although the mortality rate of premature infants is decreasing with the continuous improvement of rescue technology in the neonatal intensive care unit, more than one million young people subsequently die of premature birth-related diseases each year. The degree of premature delivery is also closely related to the morbidity and mortality of surviving infants. Therefore, more research has been conducted on telomere dysfunction in premature infants (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref> and <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>); however, to date, the regulatory mechanism of premature infants is still unclear (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B51">51</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>). However, in detecting the TL of premature infants at birth, studies showed that the TL of premature infants decreased with the increase in gestational age, which was more obvious in premature infants less than 32 weeks of age (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Casavant et al. (<xref ref-type="bibr" rid="B56">56</xref>) demonstrated in a recent study that the mean absolute length of telomeres in the peripheral blood of premature infants is greater than that of adults. The TL of males gradually becomes shorter than that of females with age. They also studied the effects of pain stimuli exposure, feeding methods, and nervous system development on the TL of premature infants. The results show that these factors have no significant effect on the absolute length of telomeres. In contrast to this, some studies showed that exposure to adverse factors (such as pain and stress) during childhood is positively related with telomere shortening, and these factors can also affect their long-term mental health (<xref ref-type="bibr" rid="B57">57</xref>&#x2013;<xref ref-type="bibr" rid="B59">59</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Evidence that telomere dysfunction causes some diseases in infants. For newborns, bronchopulmonary dysplasia is mainly associated with the respiratory system, hypoxic-ischemic encephalopathy with the nervous system, and biliary atresia with the digestive system.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-11-1133102-g001.tif"/>
</fig>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>List of telomere dysfunction-associated pediatric diseases and supporting evidence.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Disease</th>
<th valign="top" align="center">Telomere dysfunction</th>
<th valign="top" align="center">Telomere cell type</th>
<th valign="top" align="center"/>
<th valign="top" align="center">Animal model</th>
<th valign="top" align="center">Specific impact on disease</th>
<th valign="top" align="center">Refs.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="7">Preterm Infants</td>
</tr>
<tr>
<td valign="top" align="left">Biliary atresia (BA)</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">human liver cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014; severe liver cirrhosis</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Bronchopulmonary dysplasia (BPD)</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">cells from human saliva</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL &#x2014; lower FEF<sub>25&#x2212;75</sub> in extremely preterm infants</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B8">8</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014; higher serum YKL-40</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B9">9</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">shorter TL in early life of BPD children&#x2014;severe outcome in adulthood</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Hypoxic-ischemic encephalopathy (HIE)</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">nerve cells of central nervous system in rats</td>
<td valign="top" align="left"/>
<td valign="top" align="left">rat</td>
<td valign="top" align="left">TERT inhibition decreased the expression ratio of Bcl-2/Bax</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">the activated TERT has a protective effect in the hypoxic-ischemic neural model of rats</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left" colspan="7">Endocrine diseases</td>
</tr>
<tr>
<td valign="top" align="left">Obesity</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">telomere attrition rate was greater</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">cross-sectional study</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014; obesity&#x2014;only in males</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B14">14</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014; obesity&#x2014;only in females</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B15">15</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">no association between TL and childhood obesity</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no&#x00AD;&#x00AD;</td>
<td valign="top" align="left">TL &#x2014; positive correlation with SFA and DHA; negative correlation with AA/DHA ratio</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B18">18</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL &#x2014; T1D children</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B19">19</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">TL &#x2014; all-cause mortality in T1D children</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B20">20</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">TL &#x2014; negatively correlated with BMI-SDS in T1D children;</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B21">21</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL &#x2014; time of onset and course of disease; TL &#x2014; negatively correlated with HbA1c</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7">Hereditary diseases</td>
</tr>
<tr>
<td valign="top" align="left">Trisomy 21 syndrome</td>
<td valign="top" align="left">longer telomeres</td>
<td valign="top" align="left"/>
<td valign="top" align="left">Data set interest generation analysis</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">trisomy 21 patients are born with longer telomeres; Higher telomere decay rate</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Dyskeratosis congenita (DC)</td>
<td valign="top" align="left">TERT/TERC mutation</td>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">TERC RNA levels were decreased in DKC1 &#x2014;mutant cells</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B24">24</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">mutated genes affecting TL: 1. Telomerase-associated components (TERC, TERT, DKC1, NOP10, NHP2, TCAB1, NAF1, PARN); 2. Shelterin proteins (TIN2, TPP1); 3. Regulators of TL (RTEL1, CTC1, STN1)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human/mice peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">mice</td>
<td valign="top" align="left"/>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Duchenne muscular dystrophy (DMD)</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">mice muscle cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">lack of TERC &#x2014; severe muscular dystrophy</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B29">29</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">diaphragm muscles of mice</td>
<td valign="top" align="left"/>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">exercise factors can accelerate the telomere attrition</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B30">30</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">cardiomyocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">TL&#x2014;mechanosensitive in DMD</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7">Cancers</td>
</tr>
<tr>
<td valign="top" align="left">Neuroblastoma (NB)</td>
<td valign="top" align="left">TERT overexpression</td>
<td valign="top" align="left">human tumor pathological tissues and cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">TERT overexpression&#x2014;Neuroblastoma</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B32">32</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">neuroblastoma cell lines LAN-6, GI-ME-N, SK-N-FI</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">Shorter TL&#x2014;Neuroblastoma cells with telomerase activated</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Leukemia</td>
<td valign="top" align="left">High/Low TERT activity</td>
<td valign="top" align="left">human peripheral blood mononuclear cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">High TERT activity&#x2014;ALL</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human bone marrow cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">Positive correlation between telomerase activity and CDKN2B</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B35">35</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human bone marrow cells</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">low TERT activity&#x2014;AML</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Brain Tumors</td>
<td valign="top" align="left">High/Low TERT activity</td>
<td valign="top" align="left">human tumor pathological tissues</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">TERT activity&#x2014;level of differentiation (low TERT activity&#x2014;PLGGs; High TERT activity&#x2014;PHGGs)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B41">41</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7">Other system diseases</td>
</tr>
<tr>
<td valign="top" align="left">Cardiovascular system</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014;IMT in later childhood</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014;vascular elasticity but not thickness (only in adults but not in children)</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Respiratory system</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">fresh human frozen plasma</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014;STRA and CCL11 expression in children</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B44">44</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">air pollution&#x2014;shorter TL in children with asthma</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Digestive system</td>
<td valign="top" align="left">telomere attrition</td>
<td valign="top" align="left">human colon tissue biopsies<break/>human peripheral blood lymphocytes and granulocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">mice no</td>
<td valign="top" align="left">shorter TL&#x2014;activation of ATM/YAP1&#x2014; related to IBD shorter TL&#x2014;not related to IBD</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B46">46</xref>&#x2013;<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Urinary system</td>
<td valign="top" align="left">telomere attrition/TERT activity</td>
<td valign="top" align="left">human kidney pathological tissues</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">shorter TL&#x2014;complications after renal transplantation in children</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B49">49</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">human peripheral blood leukocytes</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">High TERT activity&#x2014;in children with renal transplantation</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B50">50</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>In this table, we present the evidence, specific effects of telomere dysfunction and various diseases, and cell line models and/or animal pathological models.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="s2a"><label>2.1.</label><title>Congenital biliary atresia (BA)</title>
<p>Congenital BA is the blockage of the intrahepatic and extrahepatic bile conduits, which can prompt cholestatic cirrhosis, and ultimately liver failure. It is one of the indications for liver transplantation in children and one of the most common digestive diseases in neonatal surgery. Patients with BA with hindered bile stream have determined jaundice, earth-like stool, hepatomegaly, and/or splenomegaly. If timely and reasonable intervention is not given in the early stage of the disease, most children may die at 2 years of age, with the cause of death mostly chronic liver disease (severe liver fibrosis, biliary cirrhosis, liver failure, etc.) (<xref ref-type="bibr" rid="B60">60</xref>). Hartley et al. (<xref ref-type="bibr" rid="B61">61</xref>) reported that the relative length of short telomeres in the peripheral blood of children was associated with the incidence of BA (adjusted for age and sex using logistic regression analysis). Their data also showed that the TL of patients with BA negatively correlated with the degree of liver cirrhosis. TL can also be used as one of the important indicators to evaluate the progress of BA in children (such as liver fibrosis) and is an important reference value for the timing of liver transplantation (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>).</p>
</sec>
<sec id="s2b"><label>2.2.</label><title>Bronchopulmonary dysplasia (BPD)</title>
<p>BPD is a chronic lung infection that causes constant respiratory misery. It is one of the most well-known serious diseases that influence preterm infants, particularly extremely preterm infants (Babies born before 28 weeks of pregnancy). In the long run, prolonged mechanical ventilation or oxygen inhalation may lead to stagnation of lung development, decline of vital capacity, emphysema, pulmonary hypertension, and even neurological and cognitive dysfunction. Nordlund et al. (<xref ref-type="bibr" rid="B62">62</xref>) suggested that BPD may damage the lung diffusion capacity of an infant. Airway hyperresponsiveness is more serious in premature infants than in full-term children with asthma at the same age. In a large-scale survey of young people with early pregnancy, Hadchouel et al. (<xref ref-type="bibr" rid="B8">8</xref>) showed that a shorter salivary TL was related with hindered lung capability. Previous studies also suggested that TL remained to be associated with forced expiratory flow at 25&#x0025;&#x2013;75&#x0025; of the vital capacity in preterm adolescents, after adjusting for potential confounders by multiple linear regression. Henckel et al. (<xref ref-type="bibr" rid="B9">9</xref>) suggested that in children with early BPD, chitinase-3-like protein 1 and relative TL can be used as biomarkers for long-term lung development outcomes.</p>
</sec>
<sec id="s2c"><label>2.3.</label><title>Hypoxic-ischemic encephalopathy (HIE)</title>
<p>Neonatal HIE is a severe disease caused by hypoxia in perinatal babies. Its normal cause is the fetal pain in the womb caused by different sources, such as the umbilical cord on the neck and abnormal amniotic fluid. It is very common in children who have experienced serious and life-threatening diseases (hypoxia, neonatal asphyxia) during or after childbirth, and occasionally other diseases that endanger the brain. This ordinarily happens in full-term babies, yet it can likewise happen in untimely newborn children. It has been reported that its incidence rate in live births was 1.5 &#x2030; (<xref ref-type="bibr" rid="B63">63</xref>). A total of 25&#x0025; of neonates with HIE have severe neurological complications sooner or later (<xref ref-type="bibr" rid="B64">64</xref>).Telomerase reverse transcriptase (TERT) encodes rate-limiting catalytic subunits and key regulators of telomerase activity(<xref ref-type="bibr" rid="B65">65</xref>). Some studies reported that TERT is a protective molecule against hypoxic-ischemic brain damage. This theory has been verified in HIE models of neonatal rats (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Li et al. (<xref ref-type="bibr" rid="B66">66</xref>) believed that TERT can promote cell proliferation, increase the migration and separation of sensory cells, and then reduce the apoptosis of neurons after hypoxia-ischemia. This theory has been fully confirmed in <italic>in vitro</italic> experiments. Moreover, the overexpression of TERT can activate myelination in the brain of newborn rodents. In addition, TERT overexpression reduced learning disabilities, memory ability, and neural function after hypoxic-ischemic brain injury. They also conducted in-depth research on the neuroprotective mechanism of TERT and found that the sonic hedgehog/glioma-associated oncogene 1 signaling pathway may play an important and positive role.</p>
</sec>
</sec>
<sec id="s3"><label>3.</label><title>Telomere dysfunction in nutritional and endocrine diseases in children</title>
<p>Telomere wear may be closely related to some endocrine diseases (such as diabetes) and may increase the early mortality of patients with these diseases. In some economically underdeveloped areas, children are more likely to experience various environmental stress factors, leading to malnutrition, stunting, and even fatality. Increasing evidence shows that telomere dysfunction is related to the nutritional status of and metabolic diseases in children.</p>
<sec id="s3a"><label>3.1.</label><title>Obesity in children</title>
<p>The incidence rate of childhood obesity is rising rapidly, as well as its related comorbidities, including obstructive sleep apnea syndrome, psychological problems, cardiovascular diseases, type 2 diabetes, and cancer. They seriously threaten the short- and long-term health of children. The telomerase plays a crucial role in human embryonic development. Telomerase action can result in a uniform TL in cells of different tissues, as well as differentiated cells (<xref ref-type="bibr" rid="B67">67</xref>&#x2013;<xref ref-type="bibr" rid="B69">69</xref>). The shortening rates of telomeres are high during the first three years of life (approximately 250&#x2005;bp/year) and reach a stable phase at 4 years of age. The loss rate of telomeres is stable or may decrease (approximately 50&#x2005;bp/year) from the age of 4 years to youth and old age (approximately 50&#x2005;bp/year) (<xref ref-type="bibr" rid="B70">70</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>). In children with obesity, the wear rate of telomeres is increased (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Different scholars hold different views on whether obesity is related to TL. Some research showed that there was a clear correlation between childhood obesity and shorter telomeres (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>). In contrast, others reported that there was no clear correlation between obesity and TL (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Liu et al. (<xref ref-type="bibr" rid="B18">18</xref>) reported that in preschool children with obesity, leukocyte TL shortening negatively correlated with the body mass index. They also reported that the TL of peripheral blood lymphocytes negatively correlated with arachidonic acid (AA)/ docosahexaenoic acid (DHA) ratio but positively correlated with saturated fatty acid and DHA levels, respectively. In any case, no affiliation was found between erythrocyte DHA levels and the methylation of the TERT promoter. One study likewise focused on the effect of the sex distinctions of children with obesity on TL. Other relevant studies also indicated that only the shortening of TL in males was found to be associated with the incidence of obesity; however, this association was not obvious in females (<xref ref-type="bibr" rid="B14">14</xref>).</p>
</sec>
<sec id="s3b"><label>3.2.</label><title>Diabetes in children</title>
<p>Diabetes in children is an endocrine and metabolic illness caused by the lack of insulin emission. This mainly results in carbohydrate, protein, and fat metabolism disorders, giving rise to fasting, postprandial hyperglycemia, and urine sugar. Type 1 diabetes (T1D) is common in young people and often occurs during childhood. Its main disease feature is the absolute lack of insulin, and it is a chronic immune system disease (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). Previous studies showed that the TL of children with T1D was significantly shorter than that of healthy children. In-depth follow-up studies reported that shorter telomeres were associated with all-cause mortality (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Tesovnik et al. (<xref ref-type="bibr" rid="B21">21</xref>) reported that the average TL of young people with T1D was adversely connected with the body mass index standard deviation score, and that serum vitamin D levels were not associated with TL in these individuals. In another study by Tesovnik et al. (<xref ref-type="bibr" rid="B22">22</xref>), they reported that a shorter telomere indicates an earlier and longer onset and duration of T1D; however, TL negatively correlated with glycated hemoglobin A1c. In the study of T&#x00F6;rn et al. (<xref ref-type="bibr" rid="B79">79</xref>), after a comprehensive sequencing test of the gene level of thousands of children with T1D, results showed that the age of onset negatively correlated with TL, and that children with HLA-DR4/4 or HLA-DR4/X phenotypes had longer telomeres compared with children with HLA-DR3/3 or HLA-DR/9 genes.</p>
</sec>
</sec>
<sec id="s4"><label>4.</label><title>Telomere dysfunction in hereditary diseases of children</title>
<sec id="s4a"><label>4.1.</label><title>Trisomy 21 syndrome</title>
<p>Trisomy 21 syndrome, also known as Down syndrome (DS), is caused by chromosomal abnormalities (an additional chromosome 21). Moreover, 60&#x0025; of Trisomy 21 pregnancies were miscarried in the early fetal period. Children with DS have clear mental retardation, exceptional faces, developmental obstacles, and multiple malformations. A comparative study of three different Indian trisomy 21 data sets by Bhattacharya et al. (<xref ref-type="bibr" rid="B23">23</xref>) indicated that the TL of children with trisomy 21 syndrome decreased by 58&#x2005;bps/year. In contrast, the TL of normal children decreased by 38&#x2005;bps/year. The telomere attenuation rate of children with trisomy 21 was evidently higher. However, Nakamura et al. (<xref ref-type="bibr" rid="B80">80</xref>) tested the peripheral lymphocytes (diploid, 10; trisomy 18, 10; trisomy 21, 11) of 31 live newborns. They observed that there was no measurable difference in TL among trisomy 18, trisomy 21, and diploid infants. In contrast, some studies showed that normal children have longer TL than children with trisomy 21 (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>). Thus, the above views on the divergence between TL and trisomy 21 must be further studied.</p>
</sec>
<sec id="s4b"><label>4.2.</label><title>Dyskeratosis congenita (DC)</title>
<p>Dyskeratosis congenita (DC), a multisystem inherited condition, is characterized by skin symptoms and can lead to bone marrow regeneration disorder or tumor. The inheritance of DC can be X-linked latent, autosomal predominant, or autosomal passive. Practically, patients with X-linked latent DC were male. Hoyeraal&#x2013;Hreidarsson disease, Revesz syndrome, or Coats plus disease is usually the first symptom of DC (<xref ref-type="bibr" rid="B83">83</xref>&#x2013;<xref ref-type="bibr" rid="B86">86</xref>). Some sporadic, non-classical cases are usually related to DC-related reproductive biological gene mutations, which mainly manifested as aplastic anemia, familial myelodysplastic syndromes/acute myeloid leukemia (AML) carriers, etc (<xref ref-type="bibr" rid="B87">87</xref>&#x2013;<xref ref-type="bibr" rid="B90">90</xref>).. Mutations in the genes encoding TERT, telomerase RNA component (TERC), and dyskerin pseudo uridine synthase 1 (DKC1) genes are all related to the pathogenesis of DC (<xref ref-type="bibr" rid="B91">91</xref>&#x2013;<xref ref-type="bibr" rid="B93">93</xref>). Mitchell et al. (<xref ref-type="bibr" rid="B24">24</xref>) reported that the level of TERC RNA in the DKC1-mutant cells of patients with DC was reduced. In the past years, there has been increasing evidence that gene mutations that maintain telomere gene length may increase the incidence of DC by 70&#x0025;. At present, 13 known genes have this effect (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). They include the genes encoding telomerase-associated components [TERC, TERT, DKC1, nucleolar protein 10, H/ACA ribonucleoprotein complex subunit 2, telomerase Cajal body protein 1, nuclear assembly factor 1, and poly(A)-specific ribonuclease], shelterin proteins (TERF1-interacting nuclear factor 2, tripeptidyl-peptidase 1), and other regulators of TL and replication (regulator of telomere elongation helicase 1, CTC1, STN1).</p>
</sec>
<sec id="s4c"><label>4.3.</label><title>Duchenne muscular dystrophy (DMD)</title>
<p>DMD is an X-chromosome recessive disease, which mainly occurs in males. Approximately one in each 3,500 newborn infants have this disease. Patients usually experience progressive degeneration of skeletal muscles, which gradually leads to muscle atrophy and eventually loss of motor function. These manifestations generally occur during the early-school age. It is mainly characterized by the gradual replacement of necrotic skeletal muscle cells by fibrocytes and adipocytes. Gradually, patients lose their exercise ability before and after school age, leading to death during adulthood when respiratory muscles are involved in serious cases. This disease is caused by the lack of proteins connecting the cytoskeleton and extracellular matrix, resulting in serious destruction of the integrity of the skeletal muscle cell membrane. The main genetic factors of this disease have been studied; however, its main pathogenesis must be further investigated (<xref ref-type="bibr" rid="B94">94</xref>). Sacco et al. (<xref ref-type="bibr" rid="B29">29</xref>) reported that the TL of dystrophin-deficient (mdx) mouse muscle cells lacking telomerase RNA components was shortened, leading to extremely severe malnutrition, which gradually worsened with age. The severity of muscle atrophy parallels the decline of the regeneration ability of muscle stem cells. Vita et al. (<xref ref-type="bibr" rid="B30">30</xref>) showed that in an mdx mouse model, the TL of the diaphragm was significantly shortened, and exercise factors could accelerate the telomere wear rate. Chang et al. (<xref ref-type="bibr" rid="B31">31</xref>) showed that telomere shortening is progressive, contraction-dependent, and mechanically sensitive in cardiomyocytes of DMD mice.</p>
</sec>
</sec>
<sec id="s5"><label>5.</label><title>Telomere dysfunction in pediatric cancers</title>
<p>The incidence of cancer in children ranges from 0.05 to 3 per 10,000, accounting for 1&#x0025; of all types of cancer (<xref ref-type="bibr" rid="B95">95</xref>). Childhood cancer is mostly related to congenital and genetic factors, but not strongly related to environmental factors and poor lifestyle, which is different from adult cancer. The role of telomere dysfunction in the occurrence and development of childhood cancer has gained more attention in recent years.</p>
<sec id="s5a"><label>5.1.</label><title>Neuroblastoma (NB)</title>
<p>NB is the most common extracranial tumor in children and may originate from early nerve cells of the sympathetic nerve system. Currently, only a few human tumors are known to spontaneously degenerate from undifferentiated malignant tumors to completely benign tumors, including NB. Lindner et al. (<xref ref-type="bibr" rid="B32">32</xref>) reported that the increased expression of TERT was detected in most NBs. Telomerase activation occurs in parallel with telomere shortening in NB (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B96">96</xref>). Ackermann et al. (<xref ref-type="bibr" rid="B97">97</xref>) reported that repeated genome rearrangement in the proximal 5 p15.33 chromosome region may be the reason for the overexpression of TERT in NB cells. In the biological behavior of NBs, telomerase activation and the maintenance of TL are very important and necessary links that provide relatively accurate molecular mechanisms that determine the clinical phenotype of the tumor (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s5b"><label>5.2.</label><title>Leukemia</title>
<p>Leukemia is a malignant proliferative disease of the human hematopoietic system, which seriously threaten children&#x0027;s lives. Among the types of childhood leukemia, acute lymphoblastic leukemia (ALL) and AML are the two most common, accounting for approximately 3&#x0025; of childhood malignant tumors (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). A study by Engelhardt et al. (<xref ref-type="bibr" rid="B34">34</xref>) used data from the telomerase activity of peripheral blood monocytes. Compared with healthy children, the telomerase activity of children with ALL was 10&#x2013;20 times higher. Similarly, Hu et al. (<xref ref-type="bibr" rid="B35">35</xref>) reported that the methylation of the cyclin dependent kinase inhibitor 2B gene was closely related to the telomerase activity in childhood cancer, and that telomerase activation is one of the important monitoring indicators for childhood cancer. It is interesting to note that, unlike previous perceptions, the mutation of the gene with reduced TERT activity is an important risk factor for the disease in children with AML (<xref ref-type="bibr" rid="B36">36</xref>). The telomerase activity of bone marrow cells positively correlated with prognosis in adult patients with AML, but negatively correlated with prognosis in children with AML (<xref ref-type="bibr" rid="B37">37</xref>).</p>
</sec>
<sec id="s5c"><label>5.3.</label><title>Brain tumors</title>
<p>Intracranial tumors are the most common tumors during childhood, which makes it a serious threat to the life and health of children. Its overall incidence in the population ranks second (only next to the incidence of leukemia). People of all ages may have this disease; however, its peak of occurrence is during 5&#x2013;8 years of age. In recent years, some studies have shown the close relationship between the maintenance mechanism of TL and occurrence of intracranial tumors in children (<xref ref-type="bibr" rid="B100">100</xref>&#x2013;<xref ref-type="bibr" rid="B102">102</xref>). In pediatric glioma, the level of differentiation is related to telomerase activity. Some studies suggested that according to the standards of the World Health organization, telomerase activity was significantly reduced in low-grade gliomas in children (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). In contrast, telomerase activity is significantly enhanced in most children with high-grade glioma (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Telomerase activity was increased in primary medulloblastoma but did not change in secondary medulloblastoma (<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B103">103</xref>).</p>
</sec>
</sec>
<sec id="s6"><label>6.</label><title>Pediatric diseases in other body systems</title>
<p>Telomere dysfunction is rarely studied in the pediatric diseases of other body systems, such as the cardiovascular and urinary systems. Nevertheless, we included them in this review (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref> and <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Schematic diagram of the relationship between telomere dysfunction and certain systemic disorders in older children. Acute lymphoblastic leukemia, ALL, acute myeloid leukemia; AML, dyskeratosis congenita; DC, Duchenne muscular dystrophy; DMD, Down syndrome; DS, inflammatory bowel disease; IBD, neuroblastoma; NB, type 1 diabetes, T1D. Telomere dysfunction may also be related to the body systems in children. It may be related to vascular elasticity in the cardiovascular system. In the respiratory system, it can enhance the sensitivity of the respiratory tract to air pollution. In the urinary system, it may be related to the success rate of renal transplantation.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-11-1133102-g002.tif"/>
</fig>
<p>Carotid intima-media thickness (IMT) is a risk factor for cardiovascular events in adult patients. Skilton et al. (<xref ref-type="bibr" rid="B42">42</xref>) confirmed that a shorter TL in youth was related to carotid IMT at 8 years of age but not to early life risk factors (birth weight, gestational age, skewed weight gain at the beginning, asthma, and atopy). In contrast, Nguyen et al. (<xref ref-type="bibr" rid="B43">43</xref>) reported that in middle-aged adults, TL was related with vascular versatility but not thickness. The influence of the telomere on respiratory diseases in children mainly focuses on its effect on asthma. Barbe-Tuana et al. (<xref ref-type="bibr" rid="B44">44</xref>) suggested that telomere shortening is positively related to severe therapy-resistant asthma in children, and that telomere attrition was associated with increased plasma eotaxin-1 expression in children. Lee et al. (<xref ref-type="bibr" rid="B45">45</xref>) confirmed that in children with asthma, exposure to air pollution is related to a shorter TL and that telomere wear may be reduced by steroid intervention. Similarly, Isaevska et al. (<xref ref-type="bibr" rid="B104">104</xref>) reported that for pregnant mothers, air pollution factors were related to shorter telomeres at birth, which can increase the long-term incidence of asthma and other diseases in children. In the study of Chakravarti et al. (<xref ref-type="bibr" rid="B46">46</xref>) found that telomere dysfunction leads to activation of ATM/YAP1 pathway, which is related to the pathogenesis and severity of inflammatory bowel disease (IBD).However, some scholars also believe that no evidence has been found that TL is associated with IBD in children (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>For patients undergoing renal transplantation, TL can be used as one of the indicators of long-term renal function; moreover, the incidence of renal transplantation or long-term complications is positively correlated with shorter telomeres (<xref ref-type="bibr" rid="B49">49</xref>). In contrast to adult patients, in children undergoing renal transplantation, plasma TRF2 correlated with the creatinine level and epidermal growth factor. Notably, although there is no significant difference in TL between children receiving renal transplantation and healthy children, the telomerase activity of children undergoing renal transplantation was significantly increased (<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="s7"><label>7.</label><title>Prospect of treatment</title>
<p>It can be inferred that most telomere dysfunction-related diseases are caused by TL wear; hence, considering how to enhance telomerase activity and reduce telomere wear may potentially be the main targets of treatment. There are currently two main views. One is to promote the increase in the endogenous expression of TERT. As an endogenous promoter of TERT, androgen has been widely used in the treatment of aplastic anemia (<xref ref-type="bibr" rid="B105">105</xref>). As a specific PAPD5 inhibitor, BCH001 can restore telomerase activity in patients with DC and reduce the TL wear of pluripotent stem cells (<xref ref-type="bibr" rid="B106">106</xref>). In a mouse model, TA-65 has been shown to delay telomere wear by increasing telomerase activity (<xref ref-type="bibr" rid="B107">107</xref>). Recently, as a therapeutic method, TERT was overexpressed in an adeno-associated virus vector and transfected into animal models. Significant achievements have been made in the treatment of some adult aging-related diseases such as Alzheimer&#x0027;s disease, aplastic anemia, and idiopathic pulmonary fibrosis (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B108">108</xref>&#x2013;<xref ref-type="bibr" rid="B110">110</xref>). However, these kinds of treatment have not been investigated in terms of the risk of tumor occurrence and pediatric application.</p>
<p>Telomere overexpression is common in most patients with pediatric cancers; hence, inhibiting telomerase activity may be a potential therapeutic target. The 1,3,4-Oxadiazole scaffold is a five-member heterocyclic ring, which can be used as a telomerase inhibitor in tumor therapy (<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>). As a telomerase inhibitor, imetelstat also plays a significant role in the treatment of adult AML (<xref ref-type="bibr" rid="B113">113</xref>). It can competitively inhibit the binding of telomerase and the human telomerase RNA component sequence, thereby inhibiting telomerase activity. For myelofibrosis, myelodysplastic syndrome, and other hematological malignancies, the application of imetelstat has also achieved gratifying results (<xref ref-type="bibr" rid="B114">114</xref>). As discussed above, telomerase expression in adults and children with AML is different; thus, this treatment is not applicable to children.</p>
<p>Antisense oligodeoxynucleotides (ASO) are a new class of drugs, which have gained more attention. It was confirmed in a mouse model that telomere ASO can reduce the DNA abrasion caused by telomere abrasion (<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>).</p>
<p>Most of the above treatments for telomeres are based on the treatment of diseases related to adult telomere dysfunction (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref> and <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>). Research on the treatment of telomere dysfunction-associated pediatric diseases is lacking. Therefore, both the change in telomerase activity and maintenance of TL may be potential targets for pediatric diseases.</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>In this figure, we show various treatment methods and their mechanisms in detail. Danazol, TA-65 directly increase the activity of TERT; BCH001 reduces the consumption of TERC by inhibiting PAPD5 to improve the activity of TERT; The exogenous AAV9-CMV-Tert/AAV9-Tert enhances its activity by increasing the relative number of TERT in the nucleus; 1,3,4-Oxadiazole, GRN163L; ASOs inhibit the activity of TERT.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-11-1133102-g003.tif"/>
</fig>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Prospect of treatment of telomere dysfunction-related diseases.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">TERT activation</th>
<th valign="top" align="center">treatment type</th>
<th valign="top" align="center">Representative drugs</th>
<th valign="top" align="center">Drug action</th>
<th valign="top" align="center">Animal model</th>
<th valign="top" align="center">Disease</th>
<th valign="top" align="center">Refs.</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">(1) endogenous expression of TERT</td>
<td valign="top" align="left">Androgen</td>
<td valign="top" align="left">Danazol</td>
<td valign="top" align="left"/>
<td valign="top" align="left">no</td>
<td valign="top" align="left">AA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B105">105</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">specific PAPD5 inhibitor</td>
<td valign="top" align="left">BCH001</td>
<td valign="top" align="left">enhance the activity of TERT by reducing the consumption of TERC</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">DC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B106">106</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">A special ingredient is found in the root of astragalus</td>
<td valign="top" align="left">TA-65</td>
<td valign="top" align="left">an effective telomerase activator in human immune cells, and neonatal keratinocytes and fibroblasts</td>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">Senescence</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B107">107</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">(2) Exogenous import TERT</td>
<td valign="top" align="left">gene therapy</td>
<td valign="top" align="left">AAV9-CMV-Tert</td>
<td valign="top" align="left">After overexpression of TERT <italic>in vitro</italic>, it was introduced into animal models through AAV</td>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">AD</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B108">108</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">gene therapy</td>
<td valign="top" align="left">AAV9-Tert</td>
<td valign="top" align="left">After overexpression of TERT <italic>in vitro</italic>, it was introduced into animal models through AAV</td>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">osteoporosis, glucose intolerance, AA, IPF</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B109">109</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">gene therapy</td>
<td valign="top" align="left">AAV9-Tert</td>
<td valign="top" align="left">After overexpression of TERT <italic>in vitro</italic>, it was introduced into animal models through AAV</td>
<td valign="top" align="left">mice</td>
<td valign="top" align="left">osteoporosis, neuromuscular coordination</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B110">110</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7">TERT inhibitor</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">TERT inhibitor</td>
<td valign="top" align="left">1,3,4-Oxadiazole</td>
<td valign="top" align="left">Inhibiting the activity of TERT and then inhibiting the immortalization of tumor</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">broad-spectrum anticancer activity against different cell lines</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B111">111</xref>, <xref ref-type="bibr" rid="B112">112</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">Competitive inhibitors of TERT</td>
<td valign="top" align="left">GRN163L</td>
<td valign="top" align="left">It directly binds to TERC at the enzyme catalytic site to inhibit TERT activity</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">AML</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;ASO</td>
<td valign="top" align="left">Short peptide chain</td>
<td valign="top" align="left">tASOs</td>
<td valign="top" align="left">Antisense strand RNA interference</td>
<td valign="top" align="left">no</td>
<td valign="top" align="left">DNA damage mediated by telomere attrition</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2"><p>The therapeutic targets for diseases with telomere dysfunction mainly focus on the intervention of telomerase (TERT) activity. In this table, we present potential treatments for some diseases (not limited to pediatrics): TERT activation: (1) Endogenous expression of TERT: Danazol, BCH001 TA-65; (2) Exogenous import TERT: AAV9-CMV-Tert/ AAV9-Tert; TERT inhibitor: 1,3,4-Oxadiazole, GRN163L; ASOs (Antisense oligodeoxynucleotides): Antisense strand RNA interference.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s8" sec-type="conclusions"><label>8.</label><title>Conclusions</title>
<p>Telomere dysfunction is often associated with some adult cancers and aging related diseases. Since increasing evidence show that telomere dysfunction is related to the occurrence, development, and prognosis of some pediatric diseases, we systematically analyzed the relationship between telomere biology and some pediatric congenital and growth-related diseases in this article. Similar to that of adults, shorter TL is closely related to the pathological process of some children&#x0027;s diseases. To the preterm infants, shorter TL is mainly related to BPD and BA; For older children, studies on telomere dysfunction mainly focus on the following kinds of diseases: In endocrine system diseases, the influence of shorter TL on obese children of different genders is controversial. It is clear that the shorter TL is closely related to children&#x0027;s T1D in terms of disease occurrence and all-cause mortality of diseases; For Hereditary diseases, children with DS have longer telomeres, at the same time, they have higher telomere decay rate. For children with DC and DMD, telomere dysfunction is mainly related to the abnormality of telomere RNA structure TERC; Similar to the adult cancer, the overexpression and activation of TERT were also detected in most pediatric cancer patients such as NB, Brain tumor, et al. but there are exceptions, such as AML. There are also sporadic reports that telomere dysfunction is related to other body systems, such as cardiovascular system, respiratory system, digestive system and urinary system. Most of them are related to shorter TL. An interesting hypothesis is as follows. TERT acts as an RNA-dependent reverse transcriptase in the nucleus under stable conditions. When stress events occur, ROS production in mitochondria increases. At this time, TERT will translocated to mitochondria and combine with mitochondrial circular DNA (Mit DNA) to inhibit ROS production. The relative number of TERT in the nucleus decreases, resulting in telomere attrition. (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>) Since telomere length is hereditary, it will be interesting to evaluate the correlation between the telomere length of newborns with diseases and the telomere length of their parents. This is of great significance for the long-term complications and treatment of newborns.</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>The occurrence of stress events is caused by pathogenic factors of various diseases. Mitochondrial damage increases the release of ROS, and TERT transfers from the nucleus to the mitochondria and binds with its circular DNA (Mit DNA) to inhibit the production of ROS. The reduction of the number of TERT in the nucleus leads to the wear of telomere length.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fped-11-1133102-g004.tif"/>
</fig>
<p>The length of telomeres at birth has a very important impact on the length of telomeres in children and adults. In the study of Martens DS et al. (<xref ref-type="bibr" rid="B117">117</xref>), the telomere length of newborns has a high predictive value to the telomere length of their later years. In the study of Martens DS et al. (<xref ref-type="bibr" rid="B118">118</xref>), it was found that the blood pressure of early school-age children was related to the length of telomere at birth. However, telomere length in childhood is also affected by other factors: Exposure to environmental pollution in early life is closely related to telomere wear (<xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B119">119</xref>). Socioeconomic factor, and health and lifestyle factors also related to telomere wear (<xref ref-type="bibr" rid="B120">120</xref>). Sleep duration may also have a significant impact on TL in the first few years of life (<xref ref-type="bibr" rid="B121">121</xref>).</p>
<p>Most of the current treatments considering telomeres are based on the treatment of diseases related to adult telomere dysfunction. These therapeutic targets mainly focus on the intervention of TERT activity. Danazol, and BCH001 TA-65 used for endogenous TERT expression. AAV9-CMV-Tert/ AAV9-Tert used for exogenous import TERT. 1,3,4-Oxadiazole, GRN163L used for TERT inhibitor. Antisense strand RNA interference can also be used to inhibit TERT activity. The above treatment suggestions are based on the summary of the treatment of adult diseases and the validation of animal models. If they are applied to children&#x0027;s diseases, a large number of experiments are needed to verify their safety.</p>
<p>But telomerase activity and telomere length maintenance may be potential therapeutic targets for pediatric diseases.</p>
</sec>
<sec id="s9"><title>Author contributions</title>
<p>JF conceived the review and revised the manuscript. BZ performed the search, collect the data, and took charge of writing the original manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s10" sec-type="funding-information"><title>Funding</title>
<p>This study was supported by grants from the National Natural Science Foundation of China (No. 82071688). Joint plan of Liaoning Provincial key R&#x0026;D Guidance Plan Projects of Liaoning Province (2020JH1/10300001).</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We wish to thank JF for guidance and support during completion of this review.</p>
</ack>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>LH</given-names></name><name><surname>Kao</surname><given-names>HT</given-names></name><name><surname>Burgers</surname><given-names>DE</given-names></name><name><surname>Carpenter</surname><given-names>LL</given-names></name><name><surname>Tyrka</surname><given-names>AR</given-names></name></person-group>. <article-title>Telomeres and early-life stress: an overview</article-title>. <source>Biol Psychiatry</source>. (<year>2013</year>) <volume>73</volume>(<issue>1</issue>):<fpage>15</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.06.025</pub-id><pub-id pub-id-type="pmid">22831981</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Mertens</surname><given-names>AN</given-names></name><name><surname>Arnold</surname><given-names>BF</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Stewart</surname><given-names>CP</given-names></name><etal/></person-group> <article-title>Telomere length is associated with growth in children in rural Bangladesh</article-title>. <source>Elife</source>. (<year>2021</year>) <volume>10</volume>. <pub-id pub-id-type="doi">10.7554/eLife.60389</pub-id>. [Epub ahead of print]</citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elwood</surname><given-names>N</given-names></name></person-group>. <article-title>Telomere biology of human hematopoietic stem cells</article-title>. <source>Cancer Control</source>. (<year>2004</year>) <volume>11</volume>(<issue>2</issue>):<fpage>77</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1177/107327480401100214</pub-id><pub-id pub-id-type="pmid">15024344</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosquet Enlow</surname><given-names>M</given-names></name><name><surname>Kane-Grade</surname><given-names>F</given-names></name><name><surname>De Vivo</surname><given-names>I</given-names></name><name><surname>Petty</surname><given-names>CR</given-names></name><name><surname>Nelson</surname><given-names>CA</given-names></name></person-group>. <article-title>Patterns of change in telomere length over the first three years of life in healthy children</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2020</year>) <volume>115</volume>:<fpage>104602</fpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2020.104602</pub-id><pub-id pub-id-type="pmid">32120019</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plentz</surname><given-names>RR</given-names></name><name><surname>Caselitz</surname><given-names>M</given-names></name><name><surname>Bleck</surname><given-names>JS</given-names></name><name><surname>Gebel</surname><given-names>M</given-names></name><name><surname>Flemming</surname><given-names>P</given-names></name><name><surname>Kubicka</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma</article-title>. <source>Hepatology</source>. (<year>2004</year>) <volume>40</volume>(<issue>1</issue>):<fpage>80</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/hep.20271</pub-id><pub-id pub-id-type="pmid">15239089</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiemann</surname><given-names>SU</given-names></name><name><surname>Satyanarayana</surname><given-names>A</given-names></name><name><surname>Tsahuridu</surname><given-names>M</given-names></name><name><surname>Tillmann</surname><given-names>HL</given-names></name><name><surname>Zender</surname><given-names>L</given-names></name><name><surname>Klempnauer</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis</article-title>. <source>FASEB J</source>. (<year>2002</year>) <volume>16</volume>(<issue>9</issue>):<fpage>935</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1096/fj.01-0977com</pub-id><pub-id pub-id-type="pmid">12087054</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanada</surname><given-names>Y</given-names></name><name><surname>Aida</surname><given-names>J</given-names></name><name><surname>Kawano</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Shimomura</surname><given-names>N</given-names></name><name><surname>Ishikawa</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Hepatocellular telomere length in biliary atresia measured by Q-fish</article-title>. <source>World J Surg</source>. (<year>2012</year>) <volume>36</volume>(<issue>4</issue>):<fpage>908</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s00268-012-1453-z</pub-id><pub-id pub-id-type="pmid">22311140</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hadchouel</surname><given-names>A</given-names></name><name><surname>Marchand-Martin</surname><given-names>L</given-names></name><name><surname>Franco-Montoya</surname><given-names>ML</given-names></name><name><surname>Peaudecerf</surname><given-names>L</given-names></name><name><surname>Ancel</surname><given-names>PY</given-names></name><name><surname>Delacourt</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Salivary telomere length and lung function in adolescents born very preterm: a prospective multicenter study</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>(<issue>9</issue>):<fpage>e0136123</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0136123</pub-id><pub-id pub-id-type="pmid">26355460</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henckel</surname><given-names>E</given-names></name><name><surname>James</surname><given-names>A</given-names></name><name><surname>Konradsen</surname><given-names>JR</given-names></name><name><surname>Nordlund</surname><given-names>B</given-names></name><name><surname>Kjellberg</surname><given-names>M</given-names></name><name><surname>Berggren-Brostr&#x00F6;m</surname><given-names>E</given-names></name><etal/></person-group> <article-title>A novel association between ykl-40, a marker of structural lung disease, and short telomere length in 10-year-old children with bronchopulmonary dysplasia</article-title>. <source>Children (Basel)</source>. (<year>2021</year>) <volume>8</volume>(<issue>2</issue>). <pub-id pub-id-type="doi">10.3390/children8020080</pub-id>. [Epub ahead of print]<pub-id pub-id-type="pmid">33498968</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><etal/></person-group> <article-title>The neuroprotective role and mechanisms of tert in neurons with oxygen-glucose deprivation</article-title>. <source>Neuroscience</source>. (<year>2013</year>) <volume>252</volume>:<fpage>346</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.08.015</pub-id><pub-id pub-id-type="pmid">23968592</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>D</given-names></name></person-group>. <article-title>Telomerase reverse transcriptase: a novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury</article-title>. <source>Int J Dev Neurosci</source>. (<year>2011</year>) <volume>29</volume>(<issue>8</issue>):<fpage>867</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.07.010</pub-id><pub-id pub-id-type="pmid">21827847</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benetos</surname><given-names>A</given-names></name><name><surname>Kark</surname><given-names>JD</given-names></name><name><surname>Susser</surname><given-names>E</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Sinnreich</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><etal/></person-group> <article-title>Tracking and fixed ranking of leukocyte telomere length across the adult life course</article-title>. <source>Aging Cell</source>. (<year>2013</year>) <volume>12</volume>(<issue>4</issue>):<fpage>615</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12086</pub-id><pub-id pub-id-type="pmid">23601089</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aviv</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Gardner</surname><given-names>JP</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Brimacombe</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Leukocyte telomere dynamics: longitudinal findings among young adults in the bogalusa heart study</article-title>. <source>Am J Epidemiol</source>. (<year>2009</year>) <volume>169</volume>(<issue>3</issue>):<fpage>323</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwn338</pub-id><pub-id pub-id-type="pmid">19056834</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Attas</surname><given-names>OS</given-names></name><name><surname>Al-Daghri</surname><given-names>N</given-names></name><name><surname>Bamakhramah</surname><given-names>A</given-names></name><name><surname>Shaun Sabico</surname><given-names>S</given-names></name><name><surname>McTernan</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>TT</given-names></name></person-group>. <article-title>Telomere length in relation to insulin resistance, inflammation and obesity among arab youth</article-title>. <source>Acta Paediatr</source>. (<year>2010</year>) <volume>99</volume>(<issue>6</issue>):<fpage>896</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2010.01720.x</pub-id><pub-id pub-id-type="pmid">20178511</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordfj&#x00E4;ll</surname><given-names>K</given-names></name><name><surname>Eliasson</surname><given-names>M</given-names></name><name><surname>Stegmayr</surname><given-names>B</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Roos</surname><given-names>G</given-names></name></person-group>. <article-title>Telomere length is associated with obesity parameters but with a gender difference</article-title>. <source>Obesity (Silver Spring)</source>. (<year>2008</year>) <volume>16</volume>(<issue>12</issue>):<fpage>2682</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2008.413</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kjaer</surname><given-names>TW</given-names></name><name><surname>Faurholt-Jepsen</surname><given-names>D</given-names></name><name><surname>Mehta</surname><given-names>KM</given-names></name><name><surname>Christensen</surname><given-names>VB</given-names></name><name><surname>Epel</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Shorter preschool, leukocyte telomere length is associated with obesity at age 9 in latino children</article-title>. <source>Clin Obes</source>. (<year>2018</year>) <volume>8</volume>(<issue>2</issue>):<fpage>88</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1111/cob.12233</pub-id><pub-id pub-id-type="pmid">29271129</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>DSQ</given-names></name><name><surname>Dorajoo</surname><given-names>R</given-names></name><name><surname>Gurung</surname><given-names>RL</given-names></name><name><surname>Dehghan</surname><given-names>R</given-names></name><name><surname>Lim</surname><given-names>YY</given-names></name><name><surname>Ho</surname><given-names>CWL</given-names></name><etal/></person-group> <article-title>Association of leukocyte telomere length with obesity-related traits in Asian children with early-onset obesity</article-title>. <source>Pediatr Obes</source>. (<year>2021</year>) <volume>16</volume>(<issue>8</issue>):<fpage>e12771</fpage>. <pub-id pub-id-type="doi">10.1111/ijpo.12771</pub-id><pub-id pub-id-type="pmid">33501739</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>K</given-names></name></person-group>. <article-title>Association of telomere length and telomerase methylation with N-3 fatty acids in preschool children with obesity</article-title>. <source>BMC Pediatr</source>. (<year>2021</year>) <volume>21</volume>(<issue>1</issue>):<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/s12887-020-02487-x</pub-id><pub-id pub-id-type="pmid">33413203</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeanclos</surname><given-names>E</given-names></name><name><surname>Krolewski</surname><given-names>A</given-names></name><name><surname>Skurnick</surname><given-names>J</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Aviv</surname><given-names>H</given-names></name><name><surname>Warram</surname><given-names>JH</given-names></name><etal/></person-group> <article-title>Shortened telomere length in white blood cells of patients with iddm</article-title>. <source>Diabetes</source>. (<year>1998</year>) <volume>47</volume>(<issue>3</issue>):<fpage>482</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.47.3.482</pub-id><pub-id pub-id-type="pmid">9519758</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Astrup</surname><given-names>AS</given-names></name><name><surname>Tarnow</surname><given-names>L</given-names></name><name><surname>Jorsal</surname><given-names>A</given-names></name><name><surname>Lajer</surname><given-names>M</given-names></name><name><surname>Nzietchueng</surname><given-names>R</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Telomere length predicts all-cause mortality in patients with type 1 diabetes</article-title>. <source>Diabetologia</source>. (<year>2010</year>) <volume>53</volume>(<issue>1</issue>):<fpage>45</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-009-1542-1</pub-id><pub-id pub-id-type="pmid">19802713</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tesovnik</surname><given-names>T</given-names></name><name><surname>Kovac</surname><given-names>J</given-names></name><name><surname>Hovnik</surname><given-names>T</given-names></name><name><surname>Kotnik</surname><given-names>P</given-names></name><name><surname>Battelino</surname><given-names>T</given-names></name><name><surname>Trebusak Podkrajsek</surname><given-names>K</given-names></name></person-group>. <article-title>Association of average telomere length with body-mass index and vitamin D Status in juvenile population with type 1 diabetes</article-title>. <source>Zdr Varst</source>. (<year>2015</year>) <volume>54</volume>(<issue>2</issue>):<fpage>74</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1515/sjph-2015-0011</pub-id><pub-id pub-id-type="pmid">27646911</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tesovnik</surname><given-names>T</given-names></name><name><surname>Kovac</surname><given-names>J</given-names></name><name><surname>Hovnik</surname><given-names>T</given-names></name><name><surname>Dovc</surname><given-names>K</given-names></name><name><surname>Bratina</surname><given-names>N</given-names></name><name><surname>Battelino</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Association of glycemic control and cell stress with telomere attrition in type 1 diabetes</article-title>. <source>JAMA Pediatr</source>. (<year>2018</year>) <volume>172</volume>(<issue>9</issue>):<fpage>879</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.1175</pub-id><pub-id pub-id-type="pmid">29931032</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>M</given-names></name><name><surname>Bhaumik</surname><given-names>P</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Majumder</surname><given-names>P</given-names></name><name><surname>Kumar Dey</surname><given-names>S</given-names></name></person-group>. <article-title>Telomere length inheritance and shortening in trisomy 21</article-title>. <source>Fetal Pediatr Pathol</source>. (<year>2020</year>) <volume>39</volume>(<issue>5</issue>):<fpage>390</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1080/15513815.2019.1661049</pub-id><pub-id pub-id-type="pmid">31514556</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JR</given-names></name><name><surname>Wood</surname><given-names>E</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group>. <article-title>A telomerase component is defective in the human disease dyskeratosis congenita</article-title>. <source>Nature</source>. (<year>1999</year>) <volume>402</volume>(<issue>6761</issue>):<fpage>551</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/990141</pub-id><pub-id pub-id-type="pmid">10591218</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SE</given-names></name><name><surname>Gable</surname><given-names>DL</given-names></name><name><surname>Wagner</surname><given-names>CL</given-names></name><name><surname>Carlile</surname><given-names>TM</given-names></name><name><surname>Hanumanthu</surname><given-names>VS</given-names></name><name><surname>Podlevsky</surname><given-names>JD</given-names></name><etal/></person-group> <article-title>Loss-of-function mutations in the rna biogenesis factor Naf1 predispose to pulmonary fibrosis-emphysema</article-title>. <source>Sci Transl Med</source>. (<year>2016</year>) <volume>8</volume>(<issue>351</issue>):<fpage>351ra107</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf7837</pub-id><pub-id pub-id-type="pmid">27510903</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Townsley</surname><given-names>DM</given-names></name><name><surname>Dumitriu</surname><given-names>B</given-names></name><name><surname>Young</surname><given-names>NS</given-names></name></person-group>. <article-title>Bone marrow failure and the telomeropathies</article-title>. <source>Blood</source>. (<year>2014</year>) <volume>124</volume>(<issue>18</issue>):<fpage>2775</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2014-05-526285</pub-id><pub-id pub-id-type="pmid">25237198</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertuch</surname><given-names>AA</given-names></name></person-group>. <article-title>The molecular genetics of the telomere biology disorders</article-title>. <source>RNA Biol</source>. (<year>2016</year>) <volume>13</volume>(<issue>8</issue>):<fpage>696</fpage>&#x2013;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2015.1094596</pub-id><pub-id pub-id-type="pmid">26400640</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>AJ</given-names></name><name><surname>Lev</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Weiss</surname><given-names>B</given-names></name><name><surname>Rylova</surname><given-names>A</given-names></name><name><surname>Eyal</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Mutations in Stn1 cause coats plus syndrome and are associated with genomic and telomere defects</article-title>. <source>J Exp Med</source>. (<year>2016</year>) <volume>213</volume>(<issue>8</issue>):<fpage>1429</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151618</pub-id><pub-id pub-id-type="pmid">27432940</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Mourkioti</surname><given-names>F</given-names></name><name><surname>Tran</surname><given-names>R</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Llewellyn</surname><given-names>M</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Short telomeres and stem cell exhaustion model duchenne muscular dystrophy in mdx/mtr mice</article-title>. <source>Cell</source>. (<year>2010</year>) <volume>143</volume>(<issue>7</issue>):<fpage>1059</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.11.039</pub-id><pub-id pub-id-type="pmid">21145579</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vita</surname><given-names>GL</given-names></name><name><surname>Aguennouz</surname><given-names>M</given-names></name><name><surname>Sframeli</surname><given-names>M</given-names></name><name><surname>Sanarica</surname><given-names>F</given-names></name><name><surname>Mantuano</surname><given-names>P</given-names></name><name><surname>Oteri</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Effect of exercise on telomere length and telomere proteins expression in mdx mice</article-title>. <source>Mol Cell Biochem</source>. (<year>2020</year>) <volume>470</volume>(<issue>1&#x2013;2</issue>):<fpage>189</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-020-03761-3</pub-id><pub-id pub-id-type="pmid">32447718</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>ACY</given-names></name><name><surname>Pardon</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>ACH</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Ong</surname><given-names>SG</given-names></name><name><surname>Eguchi</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Increased tissue stiffness triggers Contractile dysfunction and telomere shortening in dystrophic cardiomyocytes</article-title>. <source>Stem Cell Rep</source>. (<year>2021</year>) <volume>16</volume>(<issue>9</issue>):<fpage>2169</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2021.04.018</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>S</given-names></name><name><surname>Bachmann</surname><given-names>HS</given-names></name><name><surname>Odersky</surname><given-names>A</given-names></name><name><surname>Schaefers</surname><given-names>S</given-names></name><name><surname>Klein-Hitpass</surname><given-names>L</given-names></name><name><surname>Hero</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma</article-title>. <source>Biomed Rep</source>. (<year>2015</year>) <volume>3</volume>(<issue>4</issue>):<fpage>443</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3892/br.2015.463</pub-id><pub-id pub-id-type="pmid">26171145</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peifer</surname><given-names>M</given-names></name><name><surname>Hertwig</surname><given-names>F</given-names></name><name><surname>Roels</surname><given-names>F</given-names></name><name><surname>Dreidax</surname><given-names>D</given-names></name><name><surname>Gartlgruber</surname><given-names>M</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Telomerase activation by genomic rearrangements in high-risk neuroblastoma</article-title>. <source>Nature</source>. (<year>2015</year>) <volume>526</volume>(<issue>7575</issue>):<fpage>700</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nature14980</pub-id><pub-id pub-id-type="pmid">26466568</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>M</given-names></name><name><surname>Ozkaynak</surname><given-names>MF</given-names></name><name><surname>Drullinsky</surname><given-names>P</given-names></name><name><surname>Sandoval</surname><given-names>C</given-names></name><name><surname>Tugal</surname><given-names>O</given-names></name><name><surname>Jayabose</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy</article-title>. <source>Leukemia</source>. (<year>1998</year>) <volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/sj.leu.2400889</pub-id><pub-id pub-id-type="pmid">9436916</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wen</surname><given-names>R</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Methylation of Cdkn2b Cpg islands is associated with upregulated telomerase activity in children with acute lymphoblastic leukemia</article-title>. <source>Oncol Lett</source>. (<year>2017</year>) <volume>13</volume>(<issue>4</issue>):<fpage>2115</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2017.5710</pub-id><pub-id pub-id-type="pmid">28454370</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calado</surname><given-names>RT</given-names></name><name><surname>Regal</surname><given-names>JA</given-names></name><name><surname>Hills</surname><given-names>M</given-names></name><name><surname>Yewdell</surname><given-names>WT</given-names></name><name><surname>Dalmazzo</surname><given-names>LF</given-names></name><name><surname>Zago</surname><given-names>MA</given-names></name><etal/></person-group> <article-title>Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2009</year>) <volume>106</volume>(<issue>4</issue>):<fpage>1187</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0807057106</pub-id><pub-id pub-id-type="pmid">19147845</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verstovsek</surname><given-names>S</given-names></name><name><surname>Manshouri</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>FO</given-names></name><name><surname>Giles</surname><given-names>FJ</given-names></name><name><surname>Cortes</surname><given-names>J</given-names></name><name><surname>Estey</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia</article-title>. <source>Cancer</source>. (<year>2003</year>) <volume>97</volume>(<issue>9</issue>):<fpage>2212</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.11313</pub-id><pub-id pub-id-type="pmid">12712473</pub-id></citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tabori</surname><given-names>U</given-names></name><name><surname>Vukovic</surname><given-names>B</given-names></name><name><surname>Zielenska</surname><given-names>M</given-names></name><name><surname>Hawkins</surname><given-names>C</given-names></name><name><surname>Braude</surname><given-names>I</given-names></name><name><surname>Rutka</surname><given-names>J</given-names></name><etal/></person-group> <article-title>The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas</article-title>. <source>Neoplasia</source>. (<year>2006</year>) <volume>8</volume>(<issue>2</issue>):<fpage>136</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1593/neo.05715</pub-id><pub-id pub-id-type="pmid">16611406</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmandt</surname><given-names>SM</given-names></name><name><surname>Packer</surname><given-names>RJ</given-names></name><name><surname>Vezina</surname><given-names>LG</given-names></name><name><surname>Jane</surname><given-names>J</given-names></name></person-group>. <article-title>Spontaneous regression of low-grade astrocytomas in childhood</article-title>. <source>Pediatr Neurosurg</source>. (<year>2000</year>) <volume>32</volume>(<issue>3</issue>):<fpage>132</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1159/000028917</pub-id><pub-id pub-id-type="pmid">10867559</pub-id></citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koelsche</surname><given-names>C</given-names></name><name><surname>Sahm</surname><given-names>F</given-names></name><name><surname>Capper</surname><given-names>D</given-names></name><name><surname>Reuss</surname><given-names>D</given-names></name><name><surname>Sturm</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>DT</given-names></name><etal/></person-group> <article-title>Distribution of tert promoter mutations in pediatric and adult tumors of the nervous system</article-title>. <source>Acta Neuropathol</source>. (<year>2013</year>) <volume>126</volume>(<issue>6</issue>):<fpage>907</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1195-5</pub-id><pub-id pub-id-type="pmid">24154961</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>D</given-names></name><name><surname>Bender</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>DT</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Grill</surname><given-names>J</given-names></name><name><surname>Becher</surname><given-names>O</given-names></name><etal/></person-group> <article-title>Paediatric and adult glioblastoma: multiform (epi)Genomic culprits emerge</article-title>. <source>Nat Rev Cancer</source>. (<year>2014</year>) <volume>14</volume>(<issue>2</issue>):<fpage>92</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3655</pub-id><pub-id pub-id-type="pmid">24457416</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skilton</surname><given-names>MR</given-names></name><name><surname>Nakhla</surname><given-names>S</given-names></name><name><surname>Ayer</surname><given-names>JG</given-names></name><name><surname>Harmer</surname><given-names>JA</given-names></name><name><surname>Toelle</surname><given-names>BG</given-names></name><name><surname>Leeder</surname><given-names>SR</given-names></name><etal/></person-group> <article-title>Telomere length in early childhood: early life risk factors and association with carotid intima-media thickness in later childhood</article-title>. <source>Eur J Prev Cardiol</source>. (<year>2016</year>) <volume>23</volume>(<issue>10</issue>):<fpage>1086</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1177/2047487315607075</pub-id><pub-id pub-id-type="pmid">26405259</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>MT</given-names></name><name><surname>Vryer</surname><given-names>R</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name><name><surname>Lycett</surname><given-names>K</given-names></name><name><surname>Grobler</surname><given-names>A</given-names></name><name><surname>Dwyer</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Telomere length and vascular phenotypes in a population-based cohort of children and midlife adults</article-title>. <source>J Am Heart Assoc</source>. (<year>2019</year>) <volume>8</volume>(<issue>11</issue>):<fpage>e012707</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.119.012707</pub-id><pub-id pub-id-type="pmid">31140354</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barbe-Tuana</surname><given-names>FM</given-names></name><name><surname>Grun</surname><given-names>LK</given-names></name><name><surname>Pierdona</surname><given-names>V</given-names></name><name><surname>Parisi</surname><given-names>MM</given-names></name><name><surname>Friedrich</surname><given-names>F</given-names></name><name><surname>Guma</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Shorter telomeres in children with severe asthma, an indicative of accelerated aging</article-title>. <source>Aging (Albany NY)</source>. (<year>2021</year>) <volume>13</volume>(<issue>2</issue>):<fpage>1686</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.18632/aging.202527</pub-id><pub-id pub-id-type="pmid">33471779</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EY</given-names></name><name><surname>Oh</surname><given-names>SS</given-names></name><name><surname>White</surname><given-names>MJ</given-names></name><name><surname>Eng</surname><given-names>CS</given-names></name><name><surname>Elhawary</surname><given-names>JR</given-names></name><name><surname>Borrell</surname><given-names>LN</given-names></name><etal/></person-group> <article-title>Ambient air pollution, asthma drug response, and telomere length in African American youth</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2019</year>) <volume>144</volume>(<issue>3</issue>):<fpage>839</fpage>&#x2013;<lpage>45 e10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2019.06.009</pub-id><pub-id pub-id-type="pmid">31247265</pub-id></citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Rashid</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Telomere dysfunction activates Yap1 to drive tissue inflammation</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>(<issue>1</issue>):<fpage>4766</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-18420-w</pub-id><pub-id pub-id-type="pmid">32958778</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truta</surname><given-names>B</given-names></name><name><surname>Wohler</surname><given-names>E</given-names></name><name><surname>Sobreira</surname><given-names>N</given-names></name><name><surname>Datta</surname><given-names>LW</given-names></name><name><surname>Brant</surname><given-names>SR</given-names></name></person-group>. <article-title>Role of telomere shortening in anticipation of inflammatory bowel disease</article-title>. <source>World J Gastrointest Pharmacol Ther</source>. (<year>2020</year>) <volume>11</volume>(<issue>4</issue>):<fpage>69</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.4292/wjgpt.v11.i4.69</pub-id><pub-id pub-id-type="pmid">32953227</pub-id></citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salk</surname><given-names>JJ</given-names></name><name><surname>Bansal</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>LA</given-names></name><name><surname>Crispin</surname><given-names>DA</given-names></name><name><surname>Ussakli</surname><given-names>CH</given-names></name><name><surname>Horwitz</surname><given-names>MS</given-names></name><etal/></person-group> <article-title>Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis</article-title>. <source>Inflamm Bowel Dis</source>. (<year>2013</year>) <volume>19</volume>(<issue>12</issue>):<fpage>2593</fpage>&#x2013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0b013e3182a87640</pub-id><pub-id pub-id-type="pmid">24097228</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Domanski</surname><given-names>L</given-names></name><name><surname>Kloda</surname><given-names>K</given-names></name><name><surname>Kwiatkowska</surname><given-names>E</given-names></name><name><surname>Borowiecka</surname><given-names>E</given-names></name><name><surname>Safranow</surname><given-names>K</given-names></name><name><surname>Drozd</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study</article-title>. <source>BMC Nephrol</source>. (<year>2015</year>) <volume>16</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s12882-015-0014-8</pub-id><pub-id pub-id-type="pmid">25884882</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enden</surname><given-names>K</given-names></name><name><surname>Tainio</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Suominen</surname><given-names>A</given-names></name><name><surname>Pakarinen</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Telomere length regulators are activated in young men after pediatric kidney transplantation compared to healthy controls and survivors of childhood cancer-a cross-sectional study</article-title>. <source>Pediatr Transplant</source>. (<year>2019</year>) <volume>23</volume>(<issue>7</issue>):<fpage>e13550</fpage>. <pub-id pub-id-type="doi">10.1111/petr.13550</pub-id><pub-id pub-id-type="pmid">31297925</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salihu</surname><given-names>HM</given-names></name><name><surname>Pradhan</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>L</given-names></name><name><surname>Paothong</surname><given-names>A</given-names></name><name><surname>Nwoga</surname><given-names>C</given-names></name><name><surname>Marty</surname><given-names>PJ</given-names></name><etal/></person-group> <article-title>Impact of intrauterine tobacco exposure on fetal telomere length</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2015</year>) <volume>212</volume>(<issue>2</issue>):<fpage>205.e1</fpage>&#x2013;<lpage>e8</lpage>.<pub-id pub-id-type="doi">10.1016/j.ajog.2014.08.026</pub-id><pub-id pub-id-type="pmid">25173189</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Entringer</surname><given-names>S</given-names></name><name><surname>Epel</surname><given-names>ES</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Blackburn</surname><given-names>EH</given-names></name><name><surname>Buss</surname><given-names>C</given-names></name><name><surname>Shahbaba</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Maternal folate concentration in early pregnancy and newborn telomere length</article-title>. <source>Ann Nutr Metab</source>. (<year>2015</year>) <volume>66</volume>(<issue>4</issue>):<fpage>202</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1159/000381925</pub-id><pub-id pub-id-type="pmid">26067849</pub-id></citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchetto</surname><given-names>NM</given-names></name><name><surname>Glynn</surname><given-names>RA</given-names></name><name><surname>Ferry</surname><given-names>ML</given-names></name><name><surname>Ostojic</surname><given-names>M</given-names></name><name><surname>Wolff</surname><given-names>SM</given-names></name><name><surname>Yao</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Prenatal stress and newborn telomere length</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2016</year>) <volume>215</volume>(<issue>1</issue>):<fpage>94.e1</fpage>&#x2013;<lpage>e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2016.01.177</pub-id><pub-id pub-id-type="pmid">26829506</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Basanta-Henry</surname><given-names>P</given-names></name><name><surname>Brou</surname><given-names>L</given-names></name><name><surname>Berga</surname><given-names>SL</given-names></name><name><surname>Fortunato</surname><given-names>SJ</given-names></name><etal/></person-group> <article-title>Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes</article-title>. <source>PLoS One</source>. (<year>2012</year>) <volume>7</volume>(<issue>2</issue>):<fpage>e31136</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0031136</pub-id><pub-id pub-id-type="pmid">22348044</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedrich</surname><given-names>U</given-names></name><name><surname>Schwab</surname><given-names>M</given-names></name><name><surname>Griese</surname><given-names>EU</given-names></name><name><surname>Fritz</surname><given-names>P</given-names></name><name><surname>Klotz</surname><given-names>U</given-names></name></person-group>. <article-title>Telomeres in neonates: new insights in fetal hematopoiesis</article-title>. <source>Pediatr Res</source>. (<year>2001</year>) <volume>49</volume>(<issue>2</issue>):<fpage>252</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-200102000-00020</pub-id><pub-id pub-id-type="pmid">11158522</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casavant</surname><given-names>SG</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Reese</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Cong</surname><given-names>XS</given-names></name></person-group>. <article-title>Pilot study of absolute telomere lengths in preterm infants</article-title>. <source>Nurs Res</source>. (<year>2021</year>) <volume>70</volume>(<issue>6</issue>):<fpage>481</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/NNR.0000000000000535</pub-id><pub-id pub-id-type="pmid">34173371</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kananen</surname><given-names>L</given-names></name><name><surname>Surakka</surname><given-names>I</given-names></name><name><surname>Pirkola</surname><given-names>S</given-names></name><name><surname>Suvisaari</surname><given-names>J</given-names></name><name><surname>L&#x00F6;nnqvist</surname><given-names>J</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls</article-title>. <source>PLoS One</source>. (<year>2010</year>) <volume>5</volume>(<issue>5</issue>):<fpage>e10826</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010826</pub-id><pub-id pub-id-type="pmid">20520834</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Donovan</surname><given-names>A</given-names></name><name><surname>Pantell</surname><given-names>MS</given-names></name><name><surname>Puterman</surname><given-names>E</given-names></name><name><surname>Dhabhar</surname><given-names>FS</given-names></name><name><surname>Blackburn</surname><given-names>EH</given-names></name><name><surname>Yaffe</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Cumulative inflammatory load is associated with short leukocyte telomere length in the health, aging and body composition study</article-title>. <source>PLoS One</source>. (<year>2011</year>) <volume>6</volume>(<issue>5</issue>):<fpage>e19687</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0019687</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Provenzi</surname><given-names>L</given-names></name><name><surname>Giorda</surname><given-names>R</given-names></name><name><surname>Fumagalli</surname><given-names>M</given-names></name><name><surname>Pozzoli</surname><given-names>U</given-names></name><name><surname>Morandi</surname><given-names>F</given-names></name><name><surname>Scotto di Minico</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Pain exposure associates with telomere length erosion in very preterm infants</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2018</year>) <volume>89</volume>:<fpage>113</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.01.009</pub-id><pub-id pub-id-type="pmid">29396320</pub-id></citation></ref>
<ref id="B60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Udomsinprasert</surname><given-names>W</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name><name><surname>Chongsrisawat</surname><given-names>V</given-names></name><name><surname>Vejchapipat</surname><given-names>P</given-names></name><name><surname>Zhan</surname><given-names>D</given-names></name><name><surname>Honsawek</surname><given-names>S</given-names></name></person-group>. <article-title>Telomere length in peripheral blood leukocytes is associated with severity of biliary atresia</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>(<issue>7</issue>):<fpage>e0134689</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0134689</pub-id><pub-id pub-id-type="pmid">26230851</pub-id></citation></ref>
<ref id="B61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname><given-names>JL</given-names></name><name><surname>Davenport</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>DA</given-names></name></person-group>. <article-title>Biliary atresia</article-title>. <source>Lancet</source>. (<year>2009</year>) <volume>374</volume>(<issue>9702</issue>):<fpage>1704</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60946-6</pub-id><pub-id pub-id-type="pmid">19914515</pub-id></citation></ref>
<ref id="B62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>B</given-names></name><name><surname>James</surname><given-names>A</given-names></name><name><surname>Ebersj&#x00F6;</surname><given-names>C</given-names></name><name><surname>Hedlin</surname><given-names>G</given-names></name><name><surname>Brostr&#x00F6;m</surname><given-names>EB</given-names></name></person-group>. <article-title>Differences and similarities between bronchopulmonary dysplasia and asthma in schoolchildren</article-title>. <source>Pediatr Pulmonol</source>. (<year>2017</year>) <volume>52</volume>(<issue>9</issue>):<fpage>1179</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.23741</pub-id><pub-id pub-id-type="pmid">28636794</pub-id></citation></ref>
<ref id="B63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurinczuk</surname><given-names>JJ</given-names></name><name><surname>White-Koning</surname><given-names>M</given-names></name><name><surname>Badawi</surname><given-names>N</given-names></name></person-group>. <article-title>Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy</article-title>. <source>Early Hum Dev</source>. (<year>2010</year>) <volume>86</volume>(<issue>6</issue>):<fpage>329</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.earlhumdev.2010.05.010</pub-id><pub-id pub-id-type="pmid">20554402</pub-id></citation></ref>
<ref id="B64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magai</surname><given-names>DN</given-names></name><name><surname>Karyotaki</surname><given-names>E</given-names></name><name><surname>Mutua</surname><given-names>AM</given-names></name><name><surname>Chongwo</surname><given-names>E</given-names></name><name><surname>Nasambu</surname><given-names>C</given-names></name><name><surname>Ssewanyana</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Long-term outcomes of survivors of neonatal insults: a systematic review and meta-analysis</article-title>. <source>PLoS One</source>. (<year>2020</year>) <volume>15</volume>(<issue>4</issue>):<fpage>e0231947</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0231947</pub-id><pub-id pub-id-type="pmid">32330163</pub-id></citation></ref>
<ref id="B65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>HD</given-names></name><name><surname>West</surname><given-names>SC</given-names></name><name><surname>Beattie</surname><given-names>TL</given-names></name></person-group>. <article-title>Intertpreting telomerase structure and function</article-title>. <source>Nucleic Acids Res</source>. (<year>2010</year>) <volume>38</volume>(<issue>17</issue>):<fpage>5609</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq370</pub-id><pub-id pub-id-type="pmid">20460453</pub-id></citation></ref>
<ref id="B66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>HT</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HJ</given-names></name></person-group>. <article-title>Telomerase reverse transcriptase (tert) promotes neurogenesis after hypoxic-ischemic brain damage in neonatal rats</article-title>. <source>Neurol Res</source>. (<year>2022</year>) <volume>44</volume>(<issue>9</issue>):<fpage>819</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1080/01616412.2022.2056339</pub-id><pub-id pub-id-type="pmid">35400306</pub-id></citation></ref>
<ref id="B67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Gazitt</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Aviv</surname><given-names>A</given-names></name></person-group>. <article-title>Synchrony of telomere length among hematopoietic cells</article-title>. <source>Exp Hematol</source>. (<year>2010</year>) <volume>38</volume>(<issue>10</issue>):<fpage>854</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2010.06.010</pub-id><pub-id pub-id-type="pmid">20600576</pub-id></citation></ref>
<ref id="B68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Youngren</surname><given-names>K</given-names></name><name><surname>Jeanclos</surname><given-names>E</given-names></name><name><surname>Aviv</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Stock</surname><given-names>J</given-names></name><name><surname>Hanna</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Synchrony in telomere length of the human Fetus</article-title>. <source>Hum Genet</source>. (<year>1998</year>) <volume>102</volume>(<issue>6</issue>):<fpage>640</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1007/s004390050755</pub-id><pub-id pub-id-type="pmid">9703424</pub-id></citation></ref>
<ref id="B69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>DL</given-names></name><name><surname>Jones</surname><given-names>EL</given-names></name><name><surname>Mayer</surname><given-names>JF</given-names></name><name><surname>Oehninger</surname><given-names>S</given-names></name><name><surname>Gibbons</surname><given-names>WE</given-names></name><name><surname>Lanzendorf</surname><given-names>SE</given-names></name></person-group>. <article-title>Characterization of telomerase activity in the human oocyte and preimplantation embryo</article-title>. <source>Mol Hum Reprod</source>. (<year>2001</year>) <volume>7</volume>(<issue>10</issue>):<fpage>947</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/7.10.947</pub-id><pub-id pub-id-type="pmid">11574663</pub-id></citation></ref>
<ref id="B70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frenck</surname><given-names>RW</given-names></name><name><surname>Blackburn</surname><given-names>EH</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name></person-group>. <article-title>The rate of telomere sequence loss in human leukocytes varies with age</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1998</year>) <volume>95</volume>(<issue>10</issue>):<fpage>5607</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.10.5607</pub-id><pub-id pub-id-type="pmid">9576930</pub-id></citation></ref>
<ref id="B71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeichner</surname><given-names>SL</given-names></name><name><surname>Palumbo</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Gee</surname><given-names>D</given-names></name><name><surname>Sleasman</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Rapid telomere shortening in children</article-title>. <source>Blood</source>. (<year>1999</year>) <volume>93</volume>(<issue>9</issue>):<fpage>2824</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V93.9.2824</pub-id><pub-id pub-id-type="pmid">10216076</pub-id></citation></ref>
<ref id="B72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rufer</surname><given-names>N</given-names></name><name><surname>Br&#x00FC;mmendorf</surname><given-names>TH</given-names></name><name><surname>Kolvraa</surname><given-names>S</given-names></name><name><surname>Bischoff</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><name><surname>Wadsworth</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood</article-title>. <source>J Exp Med</source>. (<year>1999</year>) <volume>190</volume>(<issue>2</issue>):<fpage>157</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1084/jem.190.2.157</pub-id><pub-id pub-id-type="pmid">10432279</pub-id></citation></ref>
<ref id="B73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takubo</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Izumiyama</surname><given-names>N</given-names></name><name><surname>Furugori</surname><given-names>E</given-names></name><name><surname>Sawabe</surname><given-names>M</given-names></name><name><surname>Arai</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Telomere shortening with aging in human liver</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. (<year>2000</year>) <volume>55</volume>(<issue>11</issue>):<fpage>B533</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/55.11.b533</pub-id><pub-id pub-id-type="pmid">11078086</pub-id></citation></ref>
<ref id="B74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lansdorp</surname><given-names>PM</given-names></name></person-group>. <article-title>Telomeres, stem cells, and hematology</article-title>. <source>Blood</source>. (<year>2008</year>) <volume>111</volume>(<issue>4</issue>):<fpage>1759</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-09-084913</pub-id><pub-id pub-id-type="pmid">18263784</pub-id></citation></ref>
<ref id="B75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buxton</surname><given-names>JL</given-names></name><name><surname>Walters</surname><given-names>RG</given-names></name><name><surname>Visvikis-Siest</surname><given-names>S</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Blakemore</surname><given-names>AI</given-names></name></person-group>. <article-title>Childhood obesity is associated with shorter leukocyte telomere length</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2011</year>) <volume>96</volume>(<issue>5</issue>):<fpage>1500</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2010-2924</pub-id><pub-id pub-id-type="pmid">21349907</pub-id></citation></ref>
<ref id="B76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>DBP</given-names></name><name><surname>Maitre</surname><given-names>L</given-names></name><name><surname>Bustamante</surname><given-names>M</given-names></name><name><surname>Chatzi</surname><given-names>L</given-names></name><name><surname>Roumeliotaki</surname><given-names>T</given-names></name><name><surname>Fossati</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Obesity is associated with shorter telomeres in 8 year-old children</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>18739</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-55283-8</pub-id><pub-id pub-id-type="pmid">31822763</pub-id></citation></ref>
<ref id="B77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chakhtoura</surname><given-names>M</given-names></name><name><surname>Azar</surname><given-names>ST</given-names></name></person-group>. <article-title>The role of vitamin D deficiency in the incidence, progression, and complications of type 1 diabetes Mellitus</article-title>. <source>Int J Endocrinol</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>148673</fpage>. <pub-id pub-id-type="doi">10.1155/2013/148673</pub-id><pub-id pub-id-type="pmid">23573085</pub-id></citation></ref>
<ref id="B78"><label>78.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Association</surname><given-names>AD</given-names></name></person-group>. <article-title>Diagnosis and classification of diabetes mellitus</article-title>. <source>Diabetes Care</source>. (<year>2012</year>) <volume>35</volume>(<issue>Suppl 1</issue>):<fpage>S64</fpage>&#x2013;<lpage>S71</lpage>. <pub-id pub-id-type="doi">10.2337/dc12-s064</pub-id><pub-id pub-id-type="pmid">22187472</pub-id></citation></ref>
<ref id="B79"><label>79.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>T&#x00F6;rn</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Onengut-Gumuscu</surname><given-names>S</given-names></name><name><surname>Counts</surname><given-names>KM</given-names></name><name><surname>Moreno</surname><given-names>JL</given-names></name><name><surname>Remedios</surname><given-names>CL</given-names></name><etal/></person-group> <article-title>Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the teddy study</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>(<issue>1</issue>):<fpage>4516</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-08058-7</pub-id></citation></ref>
<ref id="B80"><label>80.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>N</given-names></name><name><surname>Izumiyama</surname><given-names>N</given-names></name><name><surname>Aida</surname><given-names>J</given-names></name><name><surname>Kuroiwa</surname><given-names>M</given-names></name><name><surname>Hiraishi</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Telomere lengths at birth in trisomies 18 and 21 measured by Q-fish</article-title>. <source>Gene</source>. (<year>2014</year>) <volume>533</volume>(<issue>1</issue>):<fpage>199</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.09.086</pub-id><pub-id pub-id-type="pmid">24080483</pub-id></citation></ref>
<ref id="B81"><label>81.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sukenik-Halevy</surname><given-names>R</given-names></name><name><surname>Biron-Shental</surname><given-names>T</given-names></name><name><surname>Sharony</surname><given-names>R</given-names></name><name><surname>Fejgin</surname><given-names>MD</given-names></name><name><surname>Amiel</surname><given-names>A</given-names></name></person-group>. <article-title>Telomeres in trisomy 21 amniocytes</article-title>. <source>Cytogenet Genome Res</source>. (<year>2011</year>) <volume>135</volume>(<issue>1</issue>):<fpage>12</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1159/000329714</pub-id><pub-id pub-id-type="pmid">21734364</pub-id></citation></ref>
<ref id="B82"><label>82.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>SL</given-names></name><name><surname>Hansroth</surname><given-names>J</given-names></name><name><surname>Shackelford</surname><given-names>AL</given-names></name></person-group>. <article-title>Decreased telomere length in metaphase and interphase cells from newborns with trisomy 21</article-title>. <source>Gene</source>. (<year>2014</year>) <volume>542</volume>(<issue>1</issue>):<fpage>87</fpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2014.03.019</pub-id><pub-id pub-id-type="pmid">24630967</pub-id></citation></ref>
<ref id="B83"><label>83.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>RB</given-names></name><name><surname>Gagne</surname><given-names>KE</given-names></name><name><surname>Usmani</surname><given-names>GN</given-names></name><name><surname>Asdourian</surname><given-names>GK</given-names></name><name><surname>Williams</surname><given-names>DA</given-names></name><name><surname>Hofmann</surname><given-names>I</given-names></name><etal/></person-group> <article-title>Ctc1 mutations in a patient with dyskeratosis congenita</article-title>. <source>Pediatr Blood Cancer</source>. (<year>2012</year>) <volume>59</volume>(<issue>2</issue>):<fpage>311</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/pbc.24193</pub-id><pub-id pub-id-type="pmid">22532422</pub-id></citation></ref>
<ref id="B84"><label>84.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Heiss</surname><given-names>NS</given-names></name><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Aalfs</surname><given-names>CM</given-names></name><name><surname>McMahon</surname><given-names>C</given-names></name><name><surname>Richmond</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (hoyeraal-hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, Dkc1</article-title>. <source>Br J Haematol</source>. (<year>1999</year>) <volume>107</volume>(<issue>2</issue>):<fpage>335</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2141.1999.01690.x</pub-id><pub-id pub-id-type="pmid">10583221</pub-id></citation></ref>
<ref id="B85"><label>85.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glousker</surname><given-names>G</given-names></name><name><surname>Touzot</surname><given-names>F</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>Tzfati</surname><given-names>Y</given-names></name><name><surname>Savage</surname><given-names>SA</given-names></name></person-group>. <article-title>Unraveling the pathogenesis of hoyeraal-hreidarsson syndrome, a complex telomere biology disorder</article-title>. <source>Br J Haematol</source>. (<year>2015</year>) <volume>170</volume>(<issue>4</issue>):<fpage>457</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1111/bjh.13442</pub-id><pub-id pub-id-type="pmid">25940403</pub-id></citation></ref>
<ref id="B86"><label>86.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>SA</given-names></name><name><surname>Giri</surname><given-names>N</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name></person-group>. <article-title>Tinf2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita</article-title>. <source>Am J Hum Genet</source>. (<year>2008</year>) <volume>82</volume>(<issue>2</issue>):<fpage>501</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.10.004</pub-id><pub-id pub-id-type="pmid">18252230</pub-id></citation></ref>
<ref id="B87"><label>87.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>HY</given-names></name><name><surname>Pumbo</surname><given-names>E</given-names></name><name><surname>Ivanovich</surname><given-names>J</given-names></name><name><surname>An</surname><given-names>P</given-names></name><name><surname>Maziarz</surname><given-names>RT</given-names></name><name><surname>Reiss</surname><given-names>UM</given-names></name><etal/></person-group> <article-title>Terc and tert gene mutations in patients with bone marrow failure and the significance of telomere length measurements</article-title>. <source>Blood</source>. (<year>2009</year>) <volume>113</volume>(<issue>2</issue>):<fpage>309</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-07-166421</pub-id><pub-id pub-id-type="pmid">18931339</pub-id></citation></ref>
<ref id="B88"><label>88.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirwan</surname><given-names>M</given-names></name><name><surname>Vulliamy</surname><given-names>T</given-names></name><name><surname>Marrone</surname><given-names>A</given-names></name><name><surname>Walne</surname><given-names>AJ</given-names></name><name><surname>Beswick</surname><given-names>R</given-names></name><name><surname>Hillmen</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia</article-title>. <source>Hum Mutat</source>. (<year>2009</year>) <volume>30</volume>(<issue>11</issue>):<fpage>1567</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21115</pub-id><pub-id pub-id-type="pmid">19760749</pub-id></citation></ref>
<ref id="B89"><label>89.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Lansdorp</surname><given-names>PM</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Nunez</surname><given-names>O</given-names></name><name><surname>Sloand</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Mutations of the human telomerase rna gene (Terc) in aplastic anemia and myelodysplastic syndrome</article-title>. <source>Blood</source>. (<year>2003</year>) <volume>102</volume>(<issue>3</issue>):<fpage>916</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2003-01-0335</pub-id><pub-id pub-id-type="pmid">12676774</pub-id></citation></ref>
<ref id="B90"><label>90.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Calado</surname><given-names>RT</given-names></name><name><surname>Ly</surname><given-names>H</given-names></name><name><surname>Kajigaya</surname><given-names>S</given-names></name><name><surname>Baerlocher</surname><given-names>GM</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><etal/></person-group> <article-title>Mutations in tert, the gene for telomerase reverse transcriptase, in aplastic Anemia</article-title>. <source>N Engl J Med</source>. (<year>2005</year>) <volume>352</volume>(<issue>14</issue>):<fpage>1413</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa042980</pub-id><pub-id pub-id-type="pmid">15814878</pub-id></citation></ref>
<ref id="B91"><label>91.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heiss</surname><given-names>NS</given-names></name><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Klauck</surname><given-names>SM</given-names></name><name><surname>Wiemann</surname><given-names>S</given-names></name><name><surname>Mason</surname><given-names>PJ</given-names></name><etal/></person-group> <article-title>X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions</article-title>. <source>Nat Genet</source>. (<year>1998</year>) <volume>19</volume>(<issue>1</issue>):<fpage>32</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ng0598-32</pub-id><pub-id pub-id-type="pmid">9590285</pub-id></citation></ref>
<ref id="B92"><label>92.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>SW</given-names></name><name><surname>Vulliamy</surname><given-names>TJ</given-names></name><name><surname>Heiss</surname><given-names>NS</given-names></name><name><surname>Matthijs</surname><given-names>G</given-names></name><name><surname>Devriendt</surname><given-names>K</given-names></name><name><surname>Connor</surname><given-names>JM</given-names></name><etal/></person-group> <article-title>1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis</article-title>. <source>J Med Genet</source>. (<year>1998</year>) <volume>35</volume>(<issue>12</issue>):<fpage>993</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.35.12.993</pub-id><pub-id pub-id-type="pmid">9863595</pub-id></citation></ref>
<ref id="B93"><label>93.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JR</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name></person-group>. <article-title>A box H/aca small nucleolar rna-like domain at the human telomerase Rna 3&#x2032; end</article-title>. <source>Mol Cell Biol</source>. (<year>1999</year>) <volume>19</volume>(<issue>1</issue>):<fpage>567</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.19.1.567</pub-id><pub-id pub-id-type="pmid">9858580</pub-id></citation></ref>
<ref id="B94"><label>94.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubowitz</surname><given-names>V</given-names></name></person-group>. <article-title>Commentary from the editor</article-title>. <source>Neuromuscul Disord</source>. (<year>2007</year>) <volume>17</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2006.12.005</pub-id><pub-id pub-id-type="pmid">17276884</pub-id></citation></ref>
<ref id="B95"><label>95.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steliarova-Foucher</surname><given-names>E</given-names></name><name><surname>Colombet</surname><given-names>M</given-names></name><name><surname>Ries</surname><given-names>LAG</given-names></name><name><surname>Moreno</surname><given-names>F</given-names></name><name><surname>Dolya</surname><given-names>A</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><etal/></person-group> <article-title>International incidence of childhood cancer, 2001&#x2013;10: a population-based registry study</article-title>. <source>Lancet Oncol</source>. (<year>2017</year>) <volume>18</volume>(<issue>6</issue>):<fpage>719</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(17)30186-9</pub-id><pub-id pub-id-type="pmid">28410997</pub-id></citation></ref>
<ref id="B96"><label>96.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x00ED;nez</surname><given-names>P</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name></person-group>. <article-title>Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins</article-title>. <source>Nat Rev Cancer</source>. (<year>2011</year>) <volume>11</volume>(<issue>3</issue>):<fpage>161</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3025</pub-id></citation></ref>
<ref id="B97"><label>97.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname><given-names>S</given-names></name><name><surname>Cartolano</surname><given-names>M</given-names></name><name><surname>Hero</surname><given-names>B</given-names></name><name><surname>Welte</surname><given-names>A</given-names></name><name><surname>Kahlert</surname><given-names>Y</given-names></name><name><surname>Roderwieser</surname><given-names>A</given-names></name><etal/></person-group> <article-title>A mechanistic classification of clinical phenotypes in neuroblastoma</article-title>. <source>Science</source>. (<year>2018</year>) <volume>362</volume>(<issue>6419</issue>):<fpage>1165</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1126/science.aat6768</pub-id><pub-id pub-id-type="pmid">30523111</pub-id></citation></ref>
<ref id="B98"><label>98.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>HR</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Parkin</surname><given-names>DM</given-names></name></person-group>. <article-title>Estimates of worldwide burden of cancer in 2008: globocan 2008</article-title>. <source>Int J Cancer</source>. (<year>2010</year>) <volume>127</volume>(<issue>12</issue>):<fpage>2893</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.25516</pub-id><pub-id pub-id-type="pmid">21351269</pub-id></citation></ref>
<ref id="B99"><label>99.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belson</surname><given-names>M</given-names></name><name><surname>Kingsley</surname><given-names>B</given-names></name><name><surname>Holmes</surname><given-names>A</given-names></name></person-group>. <article-title>Risk factors for acute leukemia in children: a review</article-title>. <source>Environ Health Perspect</source>. (<year>2007</year>) <volume>115</volume>(<issue>1</issue>):<fpage>138</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.9023</pub-id><pub-id pub-id-type="pmid">17366834</pub-id></citation></ref>
<ref id="B100"><label>100.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Idilli</surname><given-names>AI</given-names></name><name><surname>Cusanelli</surname><given-names>E</given-names></name><name><surname>Pagani</surname><given-names>F</given-names></name><name><surname>Berardinelli</surname><given-names>F</given-names></name><name><surname>Bernab&#x00E9;</surname><given-names>M</given-names></name><name><surname>Cayuela</surname><given-names>ML</given-names></name><etal/></person-group> <article-title>Expression of</article-title>. <source>Front Cell Dev Biol</source>. (<year>2020</year>) <volume>8</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00065</pub-id><pub-id pub-id-type="pmid">32117990</pub-id></citation></ref>
<ref id="B101"><label>101.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minasi</surname><given-names>S</given-names></name><name><surname>Baldi</surname><given-names>C</given-names></name><name><surname>Pietsch</surname><given-names>T</given-names></name><name><surname>Donofrio</surname><given-names>V</given-names></name><name><surname>Pollo</surname><given-names>B</given-names></name><name><surname>Antonelli</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Telomere elongation via alternative lengthening of telomeres (Alt) and telomerase activation in primary metastatic medulloblastoma of childhood</article-title>. <source>J Neurooncol</source>. (<year>2019</year>) <volume>142</volume>(<issue>3</issue>):<fpage>435</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-019-03127-w</pub-id><pub-id pub-id-type="pmid">30830680</pub-id></citation></ref>
<ref id="B102"><label>102.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinoff</surname><given-names>AE</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Snuderl</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>KD</given-names></name><name><surname>Manley</surname><given-names>PE</given-names></name><etal/></person-group> <article-title>Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival</article-title>. <source>J Neurooncol</source>. (<year>2017</year>) <volume>135</volume>(<issue>1</issue>):<fpage>201</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-017-2568-8</pub-id><pub-id pub-id-type="pmid">28733870</pub-id></citation></ref>
<ref id="B103"><label>103.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangerel</surname><given-names>J</given-names></name><name><surname>Price</surname><given-names>A</given-names></name><name><surname>Castelo-Branco</surname><given-names>P</given-names></name><name><surname>Brzezinski</surname><given-names>J</given-names></name><name><surname>Buczkowicz</surname><given-names>P</given-names></name><name><surname>Rakopoulos</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Alternative lengthening of telomeres is enriched in, and impacts survival of Tp53 mutant pediatric malignant brain tumors</article-title>. <source>Acta Neuropathol</source>. (<year>2014</year>) <volume>128</volume>(<issue>6</issue>):<fpage>853</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-014-1348-1</pub-id><pub-id pub-id-type="pmid">25315281</pub-id></citation></ref>
<ref id="B104"><label>104.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isaevska</surname><given-names>E</given-names></name><name><surname>Moccia</surname><given-names>C</given-names></name><name><surname>Asta</surname><given-names>F</given-names></name><name><surname>Cibella</surname><given-names>F</given-names></name><name><surname>Gagliardi</surname><given-names>L</given-names></name><name><surname>Ronfani</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Exposure to ambient air pollution in the first 1000 days of life and alterations in the DNA methylome and telomere length in children: a systematic review</article-title>. <source>Environ Res</source>. (<year>2021</year>) <volume>193</volume>:<fpage>110504</fpage>. <pub-id pub-id-type="doi">10.1016/j.envres.2020.110504</pub-id><pub-id pub-id-type="pmid">33221306</pub-id></citation></ref>
<ref id="B105"><label>105.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Townsley</surname><given-names>DM</given-names></name><name><surname>Dumitriu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Biancotto</surname><given-names>A</given-names></name><name><surname>Weinstein</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Danazol treatment for telomere diseases</article-title>. <source>N Engl J Med</source>. (<year>2016</year>) <volume>374</volume>(<issue>20</issue>):<fpage>1922</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1515319</pub-id><pub-id pub-id-type="pmid">27192671</pub-id></citation></ref>
<ref id="B106"><label>106.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Lo</surname><given-names>E</given-names></name><name><surname>Moon</surname><given-names>DH</given-names></name><name><surname>Luk</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Small-molecule Papd5 inhibitors restore telomerase activity in patient stem cells</article-title>. <source>Cell Stem Cell</source>. (<year>2020</year>) <volume>26</volume>(<issue>6</issue>):<fpage>896</fpage>&#x2013;<lpage>909 e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2020.03.016</pub-id><pub-id pub-id-type="pmid">32320679</pub-id></citation></ref>
<ref id="B107"><label>107.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernardes de Jesus</surname><given-names>B</given-names></name><name><surname>Schneeberger</surname><given-names>K</given-names></name><name><surname>Vera</surname><given-names>E</given-names></name><name><surname>Tejera</surname><given-names>A</given-names></name><name><surname>Harley</surname><given-names>CB</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name></person-group>. <article-title>The telomerase activator ta-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence</article-title>. <source>Aging Cell</source>. (<year>2011</year>) <volume>10</volume>(<issue>4</issue>):<fpage>604</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00700.x</pub-id><pub-id pub-id-type="pmid">21426483</pub-id></citation></ref>
<ref id="B108"><label>108.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittemore</surname><given-names>K</given-names></name><name><surname>Derevyanko</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>P</given-names></name><name><surname>Serrano</surname><given-names>R</given-names></name><name><surname>Pumarola</surname><given-names>M</given-names></name><name><surname>Bosch</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice</article-title>. <source>Aging (Albany NY)</source>. (<year>2019</year>) <volume>11</volume>(<issue>10</issue>):<fpage>2916</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.18632/aging.101982</pub-id><pub-id pub-id-type="pmid">31140977</pub-id></citation></ref>
<ref id="B109"><label>109.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>P</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name></person-group>. <article-title>Telomere-driven diseases and telomere-targeting therapies</article-title>. <source>J Cell Biol</source>. (<year>2017</year>) <volume>216</volume>(<issue>4</issue>):<fpage>875</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201610111</pub-id><pub-id pub-id-type="pmid">28254828</pub-id></citation></ref>
<ref id="B110"><label>110.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernardes de Jesus</surname><given-names>B</given-names></name><name><surname>Vera</surname><given-names>E</given-names></name><name><surname>Schneeberger</surname><given-names>K</given-names></name><name><surname>Tejera</surname><given-names>AM</given-names></name><name><surname>Ayuso</surname><given-names>E</given-names></name><name><surname>Bosch</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer</article-title>. <source>EMBO Mol Med</source>. (<year>2012</year>) <volume>4</volume>(<issue>8</issue>):<fpage>691</fpage>&#x2013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201200245</pub-id><pub-id pub-id-type="pmid">22585399</pub-id></citation></ref>
<ref id="B111"><label>111.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bajaj</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>PP</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name></person-group>. <article-title>1,3,4-oxadiazoles as telomerase inhibitor: potential anticancer agents</article-title>. <source>Anticancer Agents Med Chem</source>. (<year>2018</year>) <volume>17</volume>(<issue>14</issue>):<fpage>1869</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.2174/1871521409666170425092906</pub-id><pub-id pub-id-type="pmid">28443517</pub-id></citation></ref>
<ref id="B112"><label>112.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tutone</surname><given-names>M</given-names></name><name><surname>Pecoraro</surname><given-names>B</given-names></name><name><surname>Almerico</surname><given-names>AM</given-names></name></person-group>. <article-title>Investigation on quantitative structure-activity relationships of 1,3,4-oxadiazole derivatives as potential telomerase inhibitors</article-title>. <source>Curr Drug Discov Technol</source>. (<year>2020</year>) <volume>17</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.2174/1570163815666180724113208</pub-id><pub-id pub-id-type="pmid">30039762</pub-id></citation></ref>
<ref id="B113"><label>113.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saygin</surname><given-names>C</given-names></name><name><surname>Carraway</surname><given-names>HE</given-names></name></person-group>. <article-title>Current and emerging strategies for management of myelodysplastic syndromes</article-title>. <source>Blood Rev</source>. (<year>2021</year>) <volume>48</volume>:<fpage>100791</fpage>. <pub-id pub-id-type="doi">10.1016/j.blre.2020.100791</pub-id><pub-id pub-id-type="pmid">33423844</pub-id></citation></ref>
<ref id="B114"><label>114.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carloni</surname><given-names>LE</given-names></name><name><surname>Wechselberger</surname><given-names>R</given-names></name><name><surname>De Vijlder</surname><given-names>T</given-names></name></person-group>. <article-title>Characterization of in vitro G-quadruplex formation of imetelstat telomerase inhibitor</article-title>. <source>Nucleic Acid Ther</source>. (<year>2021</year>) <volume>31</volume>(<issue>5</issue>):<fpage>341</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1089/nat.2020.0918</pub-id><pub-id pub-id-type="pmid">34018844</pub-id></citation></ref>
<ref id="B115"><label>115.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossiello</surname><given-names>F</given-names></name><name><surname>Aguado</surname><given-names>J</given-names></name><name><surname>Sepe</surname><given-names>S</given-names></name><name><surname>Iannelli</surname><given-names>F</given-names></name><name><surname>Nguyen</surname><given-names>Q</given-names></name><name><surname>Pitchiaya</surname><given-names>S</given-names></name><etal/></person-group> <article-title>DNA damage response inhibition at dysfunctional telomeres by modulation of telomeric DNA damage response rnas</article-title>. <source>Nat Commun</source>. (<year>2017</year>) <volume>8</volume>:<fpage>13980</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms13980</pub-id><pub-id pub-id-type="pmid">28239143</pub-id></citation></ref>
<ref id="B116"><label>116.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aguado</surname><given-names>J</given-names></name><name><surname>Sola-Carvajal</surname><given-names>A</given-names></name><name><surname>Cancila</surname><given-names>V</given-names></name><name><surname>Revechon</surname><given-names>G</given-names></name><name><surname>Ong</surname><given-names>PF</given-names></name><name><surname>Jones-Weinert</surname><given-names>CW</given-names></name><etal/></person-group> <article-title>Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford progeria syndrome</article-title>. <source>Nat Commun</source>. (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>4990</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-13018-3</pub-id><pub-id pub-id-type="pmid">31740672</pub-id></citation></ref>
<ref id="B117"><label>117.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martens</surname><given-names>DS</given-names></name><name><surname>Van Der Stukken</surname><given-names>C</given-names></name><name><surname>Derom</surname><given-names>C</given-names></name><name><surname>Thiery</surname><given-names>E</given-names></name><name><surname>Bijnens</surname><given-names>EM</given-names></name><name><surname>Nawrot</surname><given-names>TS</given-names></name></person-group>. <article-title>Newborn telomere length predicts later life telomere length: tracking telomere length from birth to child- and adulthood</article-title>. <source>EBioMedicine</source>. (<year>2021</year>) <volume>63</volume>:<fpage>103164</fpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.103164</pub-id><pub-id pub-id-type="pmid">33422989</pub-id></citation></ref>
<ref id="B118"><label>118.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martens</surname><given-names>DS</given-names></name><name><surname>Sleurs</surname><given-names>H</given-names></name><name><surname>Dockx</surname><given-names>Y</given-names></name><name><surname>Rasking</surname><given-names>L</given-names></name><name><surname>Plusquin</surname><given-names>M</given-names></name><name><surname>Nawrot</surname><given-names>TS</given-names></name></person-group>. <article-title>Association of newborn telomere length with blood pressure in childhood</article-title>. <source>JAMA Netw Open</source>. (<year>2022</year>) <volume>5</volume>(<issue>8</issue>):<fpage>e2225521</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.25521</pub-id><pub-id pub-id-type="pmid">35930283</pub-id></citation></ref>
<ref id="B119"><label>119.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vriens</surname><given-names>A</given-names></name><name><surname>Nawrot</surname><given-names>TS</given-names></name><name><surname>Janssen</surname><given-names>BG</given-names></name><name><surname>Baeyens</surname><given-names>W</given-names></name><name><surname>Bruckers</surname><given-names>L</given-names></name><name><surname>Covaci</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Exposure to environmental pollutants and their association with biomarkers of aging: a multipollutant approach</article-title>. <source>Environ Sci Technol</source>. (<year>2019</year>) <volume>53</volume>(<issue>10</issue>):<fpage>5966</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1021/acs.est.8b07141</pub-id><pub-id pub-id-type="pmid">31041867</pub-id></citation></ref>
<ref id="B120"><label>120.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>JMP</given-names></name><name><surname>Parks</surname><given-names>CG</given-names></name><name><surname>Hyde</surname><given-names>EE</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Simanek</surname><given-names>AM</given-names></name><name><surname>Konkel</surname><given-names>RH</given-names></name><etal/></person-group> <article-title>Early life trauma and adult leucocyte telomere length</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2022</year>) <volume>144</volume>:<fpage>105876</fpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2022.105876</pub-id><pub-id pub-id-type="pmid">35939862</pub-id></citation></ref>
<ref id="B121"><label>121.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petermann-Rocha</surname><given-names>F</given-names></name><name><surname>Valera-Gran</surname><given-names>D</given-names></name><name><surname>Fernandez-Pires</surname><given-names>P</given-names></name><name><surname>Martens</surname><given-names>DS</given-names></name><name><surname>Julvez</surname><given-names>J</given-names></name><name><surname>Rodriguez-Dehli</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Children who sleep more may have longer telomeres: evidence from a longitudinal population study in Spain</article-title>. <source>Pediatr Res</source>. (<year>2022</year>). <pub-id pub-id-type="doi">10.1038/s41390-022-02255-w</pub-id>. [Epub ahead of print]<pub-id pub-id-type="pmid">35974160</pub-id></citation></ref></ref-list>
</back>
</article>